|
CKD
P1:
MYELOMA IN CHRONIC KIDNEY DISEASE (CKD): UTILITY OF DISCRETIONARY SCREENING
USING SERUM ELECTROPHOERESIS
Doyle, A, Soutar, R, Geddes, CC, Western Infirmary, Glasgow
P2: ESTABLISHMENT OF A
UK SIBLING-PAIR COLLECTION AFFECTED BY VESICOURETERIC REFLUX (VUR)
Lambert, H J1 Stewart, A1, Gullett, A M2,
Cordell, H J1, Malcolm, S2 , Feather, S A3,
Goodship, J A1, Goodship, T H J1, Woolf, A S2 on
behalf of the UK VUR DNA Development Group.
1Newcastle University, 2UCL Institute of Child Health, London, 3St
James' University Hospital, Leeds
P3:
INFORMATION ALONE IS NOT SUFFICIENT FOR PATIENTS TO MAKE DECISIONS ABOUT RENAL
REPLACEMENT THERAPY
R Elias1,2 St George’s Healthcare NHS Trust, 2St
George’s University of London
P4:
CHRONIC KIDNEY DISEASE IS A RISK FACTOR FOR CARDIOVASCULAR DISEASE AMONG
PATIENTS WITH TYPE 2 DIABETES MELLITUS
Bebb, C1, Sturrock, N, Burden, R1 Taal, M2 1Nottingham
University Hospitals, 2 Derby City General Hospital
P5: BODY
COMPOSITION IN OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: RESPONSE TO
ANTIHYPERTENSIVE THERAPY
Owen P, John S, McIntyre C, Derby City General Hospital
P6:
CROSS-SECTIONAL AUDIT OF CKD OUTPATIENT CLINIC TARGETS AND LETTERS TO GP AND
PATIENTS
Ponnusamy A, Arunachalam C, Walker A, Jafar W, Brown E, Botham H, Robinson H,
Jewell V, Lewis D, Middleton R and O’riordan E, Salford Royal Foundation Trust
P7: THE
USE OF HEMOCUE® ALBUMIN 201 AS AN EPIDEMIOLOGICAL SCREENING METHOD FOR
MICROALBUMINURIA
Kawar B1, El Nahas M1, Whitfield P2, 1Sheffield
Kidney Institute, 2Northern General Hospital, Sheffield
P8: A
YEAR AFTER eGFR – A SINGLE CENTRE REVIEW
Menon, M 1, Bavakunji, R2, Taylor, J1 1Dorset
County Hospital, Dorchester; 2Southmead Hospital, Bristol
P9: THE
ROLE OF CYSTATIN C IN ESTIMATING GFR IN BRITISH PATIENTS WITH SICKLE CELL
DISEASE
Lees, V, Sherwood, R, Thein, S W, Sharpe, CC, King’s College Hospital, London
P10:
THE VALUE OF THE CHARLSON CO-MORBIDITY SCORING INDEX IN PREDICTING OUTCOME OF
END-STAGE RENAL PATIENTS STARTING DIALYSIS IN A DISTRICT GENERAL HOSPITAL
SETTING
Ilavalagan C, Williams A and Kumwenda M, Glan Clwyd Hospital
P11:
RISK FACTORS FOR PROGRESSION TO END STAGE RENAL FAILURE IN LITHIUM-TREATED
PATIENTS
Brincat S, Yiu V, Joseph J, Mansfield N, Jones C, Kon S P, Jayawardene S,
King’s College Hospital NHS Foundation Trust
P12:
URINARY PROTEMIC ANALYSIS OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Elfaitori A1, El Nahas A M1, Bottrill A2,
Haylor J1, 1Sheffield Kidney Institute, 2University
of Leicester
P13:
MICROALBUMINURIA AND REDUCED GLOMERULAR FILTRATION RATE ARE INDEPENDENT FACTORS
FOR MORTALITY IN PEOPLE WITH DIABETES MELLITUS
Hoefield R A1, Baker P G2, Kalra P A1, Buchan
I E2, Gibson J M1, New J P1, Middleton R J1
1Salford Royal Hospital Foundation Trust, 2Manchester
University
P14:
COMPLIANCE STUDY IN PATIENTS WITH DIABETIC NEPHROPATHY
Lecamwasam, V L1, Dornhorst, A1, Tam, F W K2,
Frankel, A H2, Clifford, S3, Barrington-Ward, E 4
1Imperial College London, 2West London Renal and
Transplant Centre, Imperial College NHS Trust London, 3The School of
Pharmacy, University of London.
P15:
CHRONIC KIDNEY DISEASE AND ITS MANAGEMENT – STUDY IN PATIENTS WITH NEWLY
DIAGNOSED CEREBROVASCULAR DISEASE
Nair H, Fallouh B, Khan J, Sandler D, Dasgupta I, Heartlands Hospital,
Birmingham
P16:
COMPARISON OF PROTEIN:CREATININE AND ALBUMIN:CREATININE RATIO IN CHRONIC KIDNEY
DISEASE
MacGregor M S1, Traynor J P2, O’Reilly DSt J3, Deighan C
J3,
1Crosshouse Hospital, Kilmarnock. 2Monklands Hospital,
Airdrie. 3Glasgow Royal Infirmary
P17:
PLASMA ASYMMETRIC DIMETHYLARGININE (ADMA) AND AORTIC STIFFNESS CORRELATE WITH
CHANGE IN RENAL FUNCTION IN CHRONIC KIDNEY DISEASE
Tomlinson LA, Weaving G, Leslie AR, Rocks BF, Titheradge M, Rajkumar C, Holt SG
Brighton and Sussex Medical School, Brighton
P18:
ESTABLISHING CHRONICITY IS IMPORTANT IN DIAGNOSING CKD
Clark L1, Prescott G2, Simpson W3, Smith C2,
Fluck N4, MacLeod A1, Ali T1 1Medicine &
Therapeutics, and 2Public Health, University of Aberdeen, 3Clinical
Biochemistry, and 4Renal Unit, NHS Grampian, Aberdeen
P19:
CHRONIC RENAL INSUFFICIENCY STANDARDS IMPLEMENTATION STUDY (CRISIS): IMPACT OF
RISK FACTORS ON RRT AND MORTALITY, RESULTS OF 48 MONTH FOLLOW-UP
Hoefield, R A1, Lane, B A1, Eddington, H1,
New, J P1, Kalra, P A1, Foley, R N2,
O’Donoghue, D J1, Middleton, R J1, 1Salford
Royal Hospital Foundation Trust, 2Chronic Disease Research Group and
University of Minnesota, USA
P20:
STUDY OF CHRONIC KIDNEY DISEASE IN ANGIOGRAPHICALLY PROVEN CORONARY ARTERY
DISEASE
Nair, H 1, Khan, K 1, Fallouh, B1, Ting, S, 1,
Pitt, M1 Indranil Dasgupta, I1
1Heartlands Hospital, Birmingham
P21:
MANAGEMENT OF RENAL OUT-PATIENTS: OUTCOMES OF A CHANGE IN CLINICAL PRACTICE
Shah N, Aeddula N, John I, Kent and Canterbury Hospital
P22:
THE IMPACT OF eGFR IMPLEMENTATION ON CLINICAL PRACTICE: FINDING SOLUTIONS
THROUGH A CKD NETWORK.
Hobbs H, Farmer C, Jenkins K, John I, Kent and Canterbury Hospital
P23:
DOES THE QUALITY OF REFERRAL INFORMATION PREDICT THOSE SEEN IN NEPHROLOGY
CLINIC?
Montero RM, Joseph J, Ray S, Stowell J, Jones C, Jayawardene SA., Kings’
College Hospital, London
P24:
THE INTRODUCTION OF AN INTRAVENOUS (IV) IRON ADMINISTRATION PROGRAMME IN
PRIMARY CARE
Corner, L1, Smith, S2, Tannahill, N1. 1The
Royal Liverpool and Broadgreen University Hospitals NHS Trust, 2Liverpool
Primary Care Trust
P25:
IS THERE AN ASSOCIATION BETWEEN PRIMARY CARE RENAL QOF RETURNS AND THE NUMBER
OF REFERRALS TO THE RENAL SERVICE
Farmer, C1, Hobbs, H1, Green, S2, Irving, J1,
Stevens, P1, Wheeler, T1, O’Donoghue, D3,
Klebe, B1
1Kent and Canterbury Hospital, 2DH Vascular Team, London,
3Hope Hospital, Salford
P26:
ESTIMATING THE PREVALENCE OF CKD IN SCOTLAND AND THE IMPACT OF ROUTINE
REPORTING OF eGFR.
McCullough, K1,3, Tunstall-Pedoe, H2, MacLeod, A3, Fluck,
N1, Smith, W C4, Prescott, G4, Khan, I1, Ali, T5 Black,
C4 ,1Aberdeen Royal Infirmary, 2University of Dundee,
3Medicine and Therapeutics and4Public Health, University of Aberdeen, 5Renal
Unit, Kent and Canterbury Hospital
P27:
EFFECT OF IMPLEMENTATION OF MANAGEMENT GUIDELINES ON BLOOD PRESSURE CONTROL AND
PRESCRIBING IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 3-5 IN PRIMARY CARE
Sandhu, J1, Eardley, K2, Whiting. A I3, 1Keele
University Medical School, 2Royal Shrewsbury Hospital, 3Charlton
Medical Centre, Telford
P28:
ALBUMIN CREATININE RATIO (ACR) VERSUS PROTEIN CREATININE RATIO
(PCR) FOR NEPHROLOGY REFERRAL CRITERIA IN PRIMARY CARE
Pandya B1, Hayden K2, 1Nephrology and 2Clinical
Biochemistry, University Hospital Aintree, Liverpool
PRIMARY CARE CKD 1 (Moderated session – Wednesday)
P29:
METFORMIN, CHRONIC KIDNEY DISEASE, AND LACTIC ACIDOSIS: IS METFORMIN ABSOLUTELY
CONTRAINDICATED?
McCloskey M C, Smyth J, Marshall W, Leonard N, Renal Unit, Ulster Hospital
P30:
EFFECTS OF AN EXERCISE PROGRAMME ON UREMIC SYMPTOMS AND FUNCTIONAL PARAMETERS
OF PATIENTS WITH CHRONIC KIDNEY DISEASE
Kosmadakis G1 , Bevington A12, Smith, A1,
Clapp E3, Viana J3, Bishop N C3, Feehally J1
1Leicester General Hospital, 2University of Leicester, 3Loughborough
University
P31:
FRACTURE PREVENTION IN INSTITUTIONALISED POPULATIONS - KIDNEY FUNCTION SHOULD
BE TAKEN INTO CONSIDERATION
JL Carter1, GL Eaglestone2, SE O’Riordan3, MP Delaney2,
EJ Lamb1. Departments of 1Clinical Biochemistry, 2Renal
Medicine and 3Health Care of the Older Person, East Kent Hospitals NHS Trust
P32:
MDRD eGFR PREVALENCE OF CKD IN HEALTHY ELDERLY WHITE WOMEN IN ENGLAND
de Takats, D1 , McCloskey, E V2 1University
Hospital of North Staffordshire, 2University of Sheffield
P33:
ONE-STOP RENAL CLINIC
Kumar, S1, Gee, R2, Cartwright, S2 1Russells
Hall Hospital, Dudley, 2Dudley Primary Care Trust
P34:
VIRTUAL CKD CLINIC PROVIDES EQUIVALENT SURVEILLANCE WHEN COMPARED TO PRIMARY
CARE.
Harnett P, Grigoriou A, Almond M, Southend General Hospital
P35:
THE ANSA ANAEMIA ACADEMY – A NEW VENTURE IN SELF-DIRECTED LEARNING
Roche, A1, Johnson, C2 for and on behalf of the ANSA
executive committee
1Five Oaks Solutions, 2Derby City Hospitals NHS
Foundation Trust
P36:
RENAL DYSFUNCTION IN AN ELDERLY POPULATION ASSESSED USING THE MDRD-4 FORMULA
Shah IM, Barber M, Smith W, Monklands Hospital, Airdrie
P37: TWO
YEARS EXPERIENCE OF A DEDICATED RENAL PALLIATIVE CARE CLINIC
Hirst, G, Heatley, S, O’donnell, J, Manchester Royal Infirmary
P38:
A STAFF EXCHANGE PROGRAMME TO HELP IMPROVE THE INTERFACE BETWEEN RENAL AND
PALLIATIVE CARE SERVICES
Heatley S1, Robinson, H2, Sigsworth, E3, Braybrook, J4; 1Central
Manchester Health Care Trust, 2 Salford Royal NHS Foundation Trust,
3St Anne’s Hospice Little Hulton, 4St Anne’s Hospice Heald Green
P39:
CONSERVATIVE MANAGEMENT OF END STAGE RENAL FAILURE- IMPLEMENTING THE SUPPORTIVE
CARE PATHWAY (SCP) IN THE COMMUNITY TO IMPROVE END OF LIFE CARE
Ferris, B, Baharani, J, Heart of England Foundation Trust, Birmingham
P40:
HIGH CO-MORBIDITY SCORE IS NOT A PREDICTOR OF PLANNED MANAGEMENT IN A
PRE-DIALYSIS POPULATION
Elias R1, 2, Chandra N1, Arri S S1,
Reed A1, Streather C P1 1St George’s
Healthcare NHS Trust 2St George’s University of London
P41: THE
STORY SO FAR: COMPARING CHARACTERISTICS OF PRE-DIALYSIS PATIENTS
Pugh, J, Prichard, A, Jenkins, J, Jones, A, Thomas, N, University Hospital of
Wales, Cardiff
P42:
THE MODIFIED LIVERPOOL CARE PATHWAY IN RENAL FAILURE; ONE CENTRE’S EXPERIENCE
Brown, R1, Douglas, C2, Peters, S1, Crowe, A1,
Ledson, T1, Banerjee, A1, Daryanani, I1,
McClelland, P1
1 Wirral University Teaching Hospital, 2 Marie Curie
Hospice, Liverpool.
P43:
QUALITY OF LIFE IN CONSERVATIVELY MANAGED PATIENTS WITH eGFR OF 10 OR LESS
O Donnell, J, Hirst, G, Heatley, S, Alcock, F, Williamson, C, Central
Manchester and Manchester Childrens University Hospitals Trust
P44:
AN EVALUATION OF AN EVOLVING CONSERVATIVE CARE PROGRAMME FOR RENAL PATIENTS
Higginbotham, M, Holman, C, Jones, C, York Hospital.
P45:
WEST LONDON CONSERVATIVE CARE STUDY: A DESCRIPTIVE STUDY OF PATIENTS SELECTING
CONSERVATIVE CARE
Schmalzhaf, C, Brown, W, Dahri, L, Gifford, D, Henriksson, M, McDermott, J,
Watts, H, Brown, E A
Imperial College Healthcare NHS Trust, London.
P46: PROSPECTIVE COMPARISON OF QUALITY OF LIFE ASSESSMENTS IN PATIENTS WITH END
STAGE RENAL FAILURE TREATED CONSERVATIVELY AND THOSE ON RENAL REPLACEMENT
THERAPY
Da Silva-Gane, M1, Greenshields, H1, Hodson, C1,
Wellsted, D2, Chandna, S1, Farrington, K1
Lister Hospital1, University of Hertfordshire2
P47:
CONSERVATIVE MANAGEMENT – FOUR YEAR EXPERIENCE
Jenkins, K, Daniels, J, JOHN, I, Kent and Canterbury Hospital
P48:
CO-ORDINATED CARE FOR CONSERVATIVE MANAGEMENT PATIENTS: A BEST PRACTICE
MULTI-DISCIPLINARY APPROACH
Padmore, J, Stevens, E, Heartlands Hospital, Birmingham
P49:
RENAL PALLIATIVE CARE: THE FUTURE IS BRIGHTER– ESTABLISHING AN EFFECTIVE
PATIENT CENTRED SUSTAINABLE SERVICE
Watson S1 2, Murphy E1 2, Carey I2
Modernisation Initiative1, Guys and St Thomas’ NHS Foundation Trust2
CLINICAL NEPHROLOGY 
P50:
EVIDENCE FOR GENETIC HETEROGENEITY OF NON-SYNDROMIC AUTOSOMAL DOMINANT RENAL
HYPODYSPLASIA
Kerecuk, L1, Sanna-Cherchi, S2, Weng, P L2,
Gharavi, A G2, Flinter F A3, Woolf A S1
1Nephro-Urology Unit, UCL Institute of Child Health, London, UK 2Division
of Nephrology, Columbia University College of Physicians and Surgeons, New
York, USA , 3Genetics Department, Guy's and St. Thomas' NHS
Foundation Trust, London, UK
P51:
DISPELLING THE MYTH: USE OF ACE-I/ARB IN RENOVASCULAR DISEASE
Chrysochou C, Cheung C, Eddington H, Sinha S, Kalra PA, Salford Royal Hospitals
NHS Foundation Trust
P52:
RENAL MR ANGIOGRAPHY HAS A LOW DIAGNOSTIC YIELD - IS IT REQUESTED
APPROPRIATELY?
Das,R1, Naik,R B1, Vaux,E C1, Mohteshamzadeh,M1,
Gibson, M R2, Lc Barker, L C1
1Renal Unit, 2Radiology Department, Royal Berkshire
Hospital, Reading
P53:
DIAGNOSTIC YIELD OF NATIVE RENAL BIOPSY IN NON-PROTEINURIC KIDNEY DISEASE
Brincat S, Shah A, Yiu V, Jones C, Jayawardene S, King's College Hospital
P54:
IRAQ: THE ENVIRONMENTAL CHALLENGE TO HM LAND FORCES
WORLD, M J, Queen Elizabeth Hospital, Birmingham and Royal Centre for Defence
Medicine, Birmingham
P55:
SINGLE CENTRE SEVENTEEN YEAR EXPERIENCE OF ACUTE INTERSTITIAL NEPHRITIS
Mohammed AY, Lawrence C, Thompson BC, Warwicker P, Farrington K, Lister Renal
Unit, Stevenage
P56:
GLOMERULAR TIP CHANGES IN CHILDHOOD MINIMAL CHANGE NEPHROPATHY
Howie, A J1, Agarwal, A2, Sebire, N J3,
Trompeter, R S3
1Royal Free Hospital, 2University College, London, 3Great
Ormond Street Hospital For Children, London
P57:
SUB-CLINICAL NEPHROPATHY IN HIV PATIENTS ON ANTI-RETROVIRAL THERAPY INCLUDING
TENOFOVIR
Hall AM1,2, Edwards SG3, Lapsley M4, Connolly JO2,
Chetty K3, Unwin RJ1,2 ,Williams IG3,5.
1Department of Physiology, UCL. 2Centre for Nephrology,
UCL. 3The Mortimer Market Centre, Camden PCT. 4Epsom and St. Helier University
Hospitals NHS Trust. 5Centre for Sexual Health & HIV Research, UCL
P58:
COMPARISON OF ESTIMATED PROTEIN OUTPUT AND URINE PROTEIN: CREATININE RATIO IN
FIRST AND SECOND WITH 24 HOUR PROTEIN.
Selvarajah V, Flynn R, Isles C, Dumfries & Galloway Royal Infirmary
P59:
RENAL BIOPSY: 10-YEAR REVIEW OF PRACTICE AND HISTOLOGICAL DIAGNOSIS IN A UK
CENTRE
Smith, R, Chan, J, Rous, B, Clatworthy, M, Addenbrooke’s Hospital, Cambridge
P60:
RAPID REDUCTION OF SERUM FREE LIGHT CHAINS BY HIGH CUT-OFF HAEMODIALYSIS IN
CAST NEPHROPATHY: SUPPORTING HISTOLOGICAL EVIDENCE FROM TWO CASES
Basnayake, K1, Hutchison, C1, Kamel, D1,
Sheaff, M2, William Fuggle3, Cook, M1, Ashman, N2,
Rylance, P3, Arthur Bradwell4 Cockwell, P1 1University
Hospital Birmingham, 2Barts and the London NHS Trust, London, 3New
Cross Hospital, New Cross Hospital, Wolverhampton, 4University of
Birmingham
P61: BK
VIRUS ASSOCIATED NEPHROPATHY (BKVAN): A CAUSE OF RENAL DISEASE IN HIV/AIDS?
Byrne, C J, McCafferty, K, Pile, T, Thuraisingham, R, Sheaff, M, Barts and the
London NHS Trust, London
P62: CAN
WE PREDICT INITIATION OF DIALYSIS IN PATIENTS WITH ESRD KNOWN TO THE RENAL
SERVICES FOR AT LEAST 6 MONTHS?
Raza M N, Dudley CRK, Southmead Hospital
P63: IS
ROUTINE MEASUREMENT OF SERUM COMPLEMENT HELPFUL?
Brown, R A, Choa, R, Howse, M L P Williams, P S, Royal Liverpool University
Hospital
P64:
PREVALENCE OF LOW THIOPURINE S-METHYL TRANSFERASE (TPMT) ACTIVITY IN PATIENTS
ON AZATHIOPRINE
Oram R A, Kyle, S D, Lee, J, Bingham, C, Salzmann, M, Haigh, R, Royal Devon and
Exeter Hospital
P65:
SURVEY OF POSTGRADUATE NEPHROLOGY EDUCATION AND CLINICAL TRAINING AMONGST
NEPHROLOGISTS IN BELARUS: AN ISN MINSK-OXFORD RENAL SISTER CENTER PROJECT
Kalachyk, A1, Harden, P N2 1National Centre of
Nephrology, 4th City Hospital, Minsk, Belarus, 2Oxford Radcliffe
Hospital, Oxford
P66:
KIDNEY DISEASE IN PREGNANCY: EFFECT OF PROTEINURIA ON OUTCOMES
Hall, M, Al-Jayyousi, R, Brunskill, N, Carr, S(On Behalf Of The United Kingdom
Collaboration In Obstetrics And Renal Disease (Uk Cord)), Affiliation,
Leicester General Hospital
P67:
SERUM FREE LIGHT CHAINS – A NEW HIGHLY SENSITIVE AND SPECIFIC IMMUNOASSAY FOR
DETECTING MONOCLONAL GAMMOPATHIES IN PATIENTS WITH ACUTE RENAL FAILURE
Hutchison C A, Plant T, Drayson M, Basnayake K Cockwell P, University Hospital
Birmingham
P68:
MYELOMA AND RENAL FAILURE – OUTCOME AT 1 YEAR IN PATIENTS REFERRED TO A
TERTIARY RENAL SERVICE
Makanjuola, D, Varrier, M, Ahmed, S, Chalisey, A, Ravindranathan, G,
Indrakumar, T, Behrens, J
St Helier Hospital, Carshalton
P69:
RISK STRATIFICATION FOR DIABETIC FOOT DISEASE ON RENAL PATIENTS USING FOOT AT
RISK ASSESSMENT TOOL – A PILOT STUDY
Lawrence, A, Spratley, M, Coward, T, Tam, F, Turner, J1, Frankel, A
H, Imperial College Healthcare NHS Trust, 1Imperial College London
P70:
HAVE METFORMIN PRESCRIBING PATTERNS IN PRIMARY CARE CHANGED SINCE THE
INTRODUCTION OF ROUTINE GLOMERULAR FILTRATION RATE REPORTING?
Kilbride, H, Irving, J, Stevens, P E, Hobbs, H, Klebe, B, Farmer, C, Kent and
Canterbury Hospital
P71:
METFORMIN; CONTROVERSY RE RENAL CONTRAINDICATIONS. COMPARING NEPHROLOGISTS AND
ENDOCRINOLOGISTS PERSPECTIVES
Browne, S1, Kearney, E1, Dinneen, S2, Lappin,
D1 1Department of Nephrology and 2Department
of Endocrinology, National University of Ireland (NUI), Galway
P72:
THE IMPLICATIONS OF THE MODIFICATION OF DIET IN RENAL DISEASE EQUATION IN
PHARMACY PRACTICE
Fleming A, Beaumont Hospital, Dublin.
P73: CAN
WE MAXIMISE THE BENEFITS OF PNEUMOCOCCAL VACCINATION [PV] IN PATIENTS WITH
CHRONIC KIDNEY DISEASE?
Naik R, Vaux E, Barker L, Mohteshamzadeh M, Tuckett J, Royal Berkshire Hospital
NHS Trust
P74:
EFFECTS OF STATINS ON SELENIUM METABOLISM IN RENAL PATIENTS
Park, A1, Sampson, B1, Frankel, A H2
1Department of Clinical Chemistry & 2West London
Renal & Transplant Centre, Imperial NHS Trust
P75:
IMPACT OF AN ALGORITHM-DRIVEN PROCESS FOR HEPATITIS B IMMUNISATION IN THE RENAL
UNIT
Powell J, Schneider A, Geddes CC, Western Infirmary, Glasgow
P76:
SEVELAMER AND LEVOTHYROXINE: TIMING OF DOSAGE TO AVOID INTERACTION
Hussain S, Henderson I, Ninewells Hospital & Medical School, Dundee
P77:
IMPLEMENTING SEAMLESS CARE TO IMPROVE A HEPATITIS B VACCINATION PROGRAMME: THE
KEY TO SUCCESS
Anderson D, University Hospitals of Leicester NHS Trust
P78:
AN AUDIT OF A PROGRAMME OF PROACTIVE PRE-DIALYSIS VACCINATION AGAINST HEPATITIS
B
Ridley L, Jones C, York Hospital
P79:
PROVIDING WRITTEN INFORMATION FOR RENAL PATIENTS RECEIVING THERAPY FOR ANCA-
ASSOCIATED VASCULITIDES
Lamerton E, Salford Royal NHS Foundation Trust
P80:
SETTING UP A SATELLITE HAEMODIALYSIS UNIT DESIGNED FOR CONTINUOUS QUALITY
IMPROVEMENT BY EVOLVING A BALANCED SCORECARD APPROACH
Gregson J, Hegarty J, Salford Royal NHS Foundation Trust
P81: A
HOME HAEMODIALYSIS PATIENT TRAINING PROGRAMME
Dutton G, Manchester Royal Infirmary
P82:
KIDNEY FAILURE SUPPORT TEAM, A NEW NAME FOR AN EXPANDING SERVICE
Dodds A, Tebbit L, Price A, Ferris B, Heart of England NHS Foundation Trust
P83:
MULTIDISCIPLINARY CARE IMPROVES OUTCOME OF PATIENTS WITH STAGE 5 CHRONIC KIDNEY
DISEASE
Dasgupta I, Fenton A, Sayer Z, Dodds A, Heartlands Hospital, Birmingham
P84:
CLINICAL COMPETENCIES – WHO NEEDS THEM?
Allen E, Kinton R, McGoran A, TaylorK, Mid Trent Renal Specialist Competency
Group
P85:
FIVE YEARS AFTER ITS CREATION, MULTIDISCIPLINARY LOW CLEARANCE CLINIC STILL
CONTINUES TO OFFER QUALITY BENEFITS IN A SINGLE DEPARTMENT OF NEPHROLOGY
Patel R S1, Medcalf J1, Carr S1, Bankart J2,
1Leicester General Hospital, 2University of Leicester
P86: AN
EVALUATION OF THE CLINIC LETTERS AS A MEANS OF IMPROVING PATIENT-DOCTOR
COMMUNICATION HAS BEEN SUBMITTED AND RECORDED IN OUR DATABASE
Jones C, York Hospital, Renal Unit
P87:
UPTAKE OF AND ADHERENCE TO INTRADIALYTIC EXERCISE: CAN IT BE IMPROVED WITH THE
SUPPORT OF A PHYSIOTHERAPY ASSISTANT?
Pursey VA, Worth D P, Thomas E S, York Hospital
P88:
ACTION LEARNING – AN EFFECTIVE METHOD FOR SERVICE DEVELOPMENT?
Jones C, York Hospital
P89:
Dialysis Unit Systems Redesign To Improve Reliability
Furness S, Chanayireh M, Hegarty J, Salford Royal NHS Foundation Trust.
P90:
CO-PRODUCTION OF A PATIENT- HELD CARE PLAN
Green D, Gregson J, Butler E, Clark D, Jose A, Mulwa E, Shantappa A, Wilson C,
Sankey D, Hegarty J
Salford Royal Foundation Trust
P91:
AN INNOVATIVE RENAL DIETARY RESOURCE
Devenish R, M Udeshi M, Royal Free Hospital, London.
P92:
PROVISION OF DIETARY ADVICE AND USE OF PHOSPHATE BINDERS AND ACTIVATED VITAMIN
D IN PRE-DIALYSIS PATIENTS: AN AUDIT
Lindley, E1, Evans, A2, Mooney, A1, Woodrow, G1
Wright, M1 1Department of Renal Medicine 2Department
of Nutrition and Dietetics, St James Hospital, Leeds
P93:
TRAINING ON THE GO
Manji T1, Willis C2 Birmingham Heartlands Hospital
P94:
NHSI DQV FOCUS ON: PREPARATION FOR END STAGE RENAL DISEASE
Webb M1, Davies C2, Hawkins J2 1 East
Kent Hospital Trust 2NHSI, Warwick University Campus
P95:
THE IMPACT OF A MULTI-PROFESSIONAL CARE PATHWAY FOR VASCULAR ACCESS
Daniel S, Savage T, Abey-Koch L, Bell M, Armitage A, Mitchell D, Southmead
Hospital, Bristol
P96:
SETTING UP A COLLABORATIVE NORTH WEST LIVING KIDNEY DONOR WEBSITE
Hyde A1 Hegarty J1, Kost S2, Gill, J2,
Biggins F3, Picton M2, Riad H2, Augustine T2 Parrott
N2, Campbell T2, Pararajasingham R2,Tavakoli A2
J,Colbeck L & J2, Cowpe, J & S3
1Salford Royal NHS Foundation Trust, 2Manchester Royal
Infirmary, 3Royal Preston Hospital
P97:
IMPLEMENTATION OF A TRANSPLANT DATABASE TO IMPROVE PATIENTS ACTIVITY
Scroby K, Salford Royal Hospital Trust
P98:
LOOKING FOR TROUBLE: CAN ARTERIOVENOUS FISTULAE OCCLUSION BE PREDICTED USING
ROUTINELY COLLECTED DIALYSIS MEASUREMENTS?
Oliphant R, Jaidka R, Geddes C, Kingsmore D, Western Infirmary, Glasgow
P99: ANTIMICROBIAL INTERVENTIONS
FOR THE PREVENTION OF HAEMODIALYSIS CATHETER-RELATED INFECTIONS: A SYSTEMATIC
REVIEW OF RANDOMISED CONTROLLED TRIALS HAS BEEN SUBMITTED AND RECORDED IN OUR
DATABASE
Bansal T 1, Adams J2 , Das R 3, Macleod A4,
Moore C ⁵, Besarab A ⁵, Rabindranath K ⁶1Royal London Hospital 2Kings
College Hospital , 3Royal Berkshire Hospital , 4University
of Aberdeen , ⁵Henry Ford Health System, Detroit ,⁶ Churchill Hospital
P100:
IMPLEMENTING CHANGE - THE INTRODUCTION OF A PILOT BUTTON-HOLE CANNULATION
PROGRAMME INTO ROUTINE CLINICAL PRACTICE
Pearce C, Wilson C, Love M, Freeman Hospital, Newcastle
P101:
PERMANENT VASCULAR ACCESS AND PATIENT SURVIVAL: RETROSPECTIVE ANALYSIS OF
8-YEAR DATA
Blakemore, E, Williams, A, Baikunje, S, Kumwenda,M J, Glan Clwyd Hospital
P102:
ARTERIO-VENOUS FISTULA CANNULATION: WHAT DO PATIENTS AND DIALYSIS NURSES THINK
ABOUT CURRENT NEEDLING PRACTICE AND IS THERE A NEED FOR CHANGE?
Vaux E, King J, Lloyd S, Moore J, Royal Berkshire NHS Foundation Trust
P103:
BACK TO BASICS: BANISHING THE BUGS IN A BUSY DIALYSIS UNIT
Vaux E, King J, Moore J, Barker L, Mohteshamzadeh M, Naik R, Royal Berkshire
NHS Foundation Trust
P104:
HIGHER ARTERIOVENOUS FISTULAE BLOOD FLOWS ARE ASSOCIATED WITH A LOWER LEVEL OF
DIALYSIS INDUCED CARDIAC INJURY
Korsheed S1,Burton JO1, McIntyre CW1, 2,
1Derby City General Hospital, 2University of Nottingham
P105:
FACTORS INFLUENCING THE ESTABLISHMENT OF DEFINITIVE VASCULAR ACCESS IN A
HAEMODIALYSIS COHORT
Borthwick E, Mullan R, Cunningham R, Harron C, Antrim Area Hospital, Northern
Ireland
ACCESS 2 (Moderated session – Thursday)
P106:
A PROSPECTIVE STUDY OF HEPARINISED CATHETER LOCK SOLUTIONS IN NON-TUNNELLED
DUAL-LUMEN CENTRAL VENOUS HAEMODIALYSIS CATHETERS
Thomson P C, Morris S T W, Mactier R A, Glasgow Royal Infirmary
P107:
AN IN-VITRO ANALYSIS OF VANCOMYCIN IN COMBINATION WITH HEPARIN AS HAEMODIALYSIS
CATHETER-LOCK SOLUTION
Thomson P1, Morris S1, Mactier R1, Lang S2
, 1Glasgow Royal Infirmary, 2Glasgow Caledonian
University
P108:
THE IMPACT OF A VASCULAR ACCESS MULTI-PROFESSIONAL CARE PATHWAY ON DIAGNOSTIC
IMAGING AND INTERVENTIONAL RADIOLOGY
Weale A, Bell M, Damji S, Collin N, Abey-Koch L, Armitage A, Thornton M,
Mitchell D
Southmead Hospital, Bristol
P109:
VASCULAR ACCESS FOR HAEMODIALYSIS IN THE ELDERLY
Cacciola R, Swindlehurst A, Carter N, Lumgair H, Mamode, N, Guy’s Hospital
Transplant Unit, London
P110:
CREATION OF AN ARTERIOVENOUS FISTULA IS ASSOCIATED WITH SIGNIFICANT CHANGES IN
SYSTEMIC CARDIOVASCULAR PERFORMANCE
Korsheed S1, Kwok Yi C1, McIntyre CW1, 2.
, 1Derby City General Hospital, 2University of Nottingham
P111:
BACTERIAL ENDOCARDITIS FOLLOWING TUNNELLED DIALYSIS CATHETER INSERTION: IMPACT
OF PRE-EXISTING MITRAL VALVE DISEASE
Green D, Wilson A J, Dunne P D, Wood G N I, New D, Lewis D, Salford Royal
Foundation NHS Trust
P112:
OUTCOME OF PRE-DIALYSIS PATIENTS FOLLOWING ARTERIOVENOUS FISTULA FORMATION: A
SINGLE CENTRE STUDY
Bolton, S 1, Kuan, Y 2, 1Belfast City
Hospital, 2Altnagelvin Area Hospital
P113:
HIGH PREVALENCE OF ABNORMAL MICROVOLT T WAVE ALTERNANS RESULTS IN END STAGE
RENAL FAILURE PATIENTS
Patel R K, Cobbe S C, Jardine A G, University Of Glasgow
P114:
IMPLEMENTING AN EASY AND PRACTICAL METHOD OF FOOT EXAMINATION IN A HD UNIT
Crawford G, McHugh C, Altnagelvin Hospital Trust,Derry
P115:
HOME HAEMODIALYSIS: A SINGLE CENTRE EXPERIENCE SINCE 2002 NICE Guidelines
Chatterjee D, Coward R A, Woywodt A, Gibson S P, Morris B, Wroe C, Royal
Preston Hospital
P116:
INDIVIDUALISED DIALYSATE BICARBONATE PRESCRIBING IN HAEMODIALYSIS PATIENTS -
ITS EFFECT ON BIOCHEMICAL PARAMETERS AND DIALYSIS ADEQUACY
Bubtana A, Mapindan L, Mohammed I, Mitra S, Central Manchester & Manchester
Children’s Hospital
P117: HBA1C IS A POOR INDICATOR OF GLYCAEMIC CONTROL IN PATIENTS WITH DIABETES
ON HAEMODIALYSIS
Kazempour-Ardebili S1, Lecamwasam V2, Hurril R 2,
Tam F 2, Turner J 1, Dassanayake T 3, Andrew H Frankel 2,
Dornhorst A1
1Imperial College London, 2West London Renal And
Transplant Centre, Imperial College Healthcare Nhs Trust, 3Department
Of Nutrition And Dietetics, Imperial College Healthcare Nhs Trust
P118: ASSESSMENT OF THROMBOTIC AND THROMBOLYTIC STATUS OF PATIENTS PRIOR TO
HAEMODIALYSIS: A PILOT STUDY.
Ben Salha I, Saraf S, Farrington K, Gorog D A, East and North Hertfordshire NHS
Trust
P119:
USE OF LOW MOLECULAR WEIGHT HEPARIN (TINZAPARIN) IN HIGH FLUX DIALYSIS AND HDF
Sivalingam M, Peasegood J, Mouatt S, Farrington K, Lister Hospital, Stevenage
P120:
TEN YEARS EXPERIENCE OF LONG OVERNIGHT HAEMODIALYSIS
Oluwaseun O1, Padmanabhan N1, Latta C2, Woo Y
M3, Tortolano J1, Jardine A G1, Geddes C C1.
1Western Infirmary, Glasgow, 2Gartnavel General Hospital,
3Inverclyde Royal Hospital, Greenock
P121: CASE REPORT
OF SUCCESSFUL PREGNANCY IN YOUNG WOMAN ON MAINTENANCE HAEMODIALYSIS
Wessels J, Kaniyamparambil F, University Hospital of North Staffordshire
HD GENERAL 2 (Moderated session – Thursday)
P122:
HIGH BODY MASS INDEX (BMI) IS NOT ASSOCIATED WITH IMPROVED LONGTERM SURVIVAL IN
PATIENTS USING PERITONEAL OR HAEMODIALYSIS (HD) FOR ESTABLISHED RENAL FAILURE
(ERF)
Simms R2, Doyle A1, Simpson K3, 1Western
Infirmary, Glasgow, 2Freeman Hospital, Newcastle-Upon-Tyne, 3Glasgow
Royal Infirmary
P123:
SAFETY, TOLERABILITY AND PATIENT SATISFACTION WITH COMPLEMENTARY THERAPIES ON
HAEMODIALYSIS
Sankey D, Hampson N, Lewis W, Heath J, Mcconnell P, Marshall M, Clegg R, Kelly
L, Gregson J, Hegarty J, Wigan Renal Unit
P124:
DOES ALTERING PHYSICAL AND BIOCHEMICAL PARAMETERS AFFECT SEGMENTAL BIOIMPEDANCE
MEASUREMENTS IN HAEMODIALYSIS PATIENTS?
Castledine C, Suresh M, Farrington K, Lister Hospital, Stevenage
P125:
PREVALENCE OF OBSTRUCTIVE SLEEP APNOEA IN HAEMODIALYSIS PATIENTS
Sivalingam M, Mouatt S, Chakravorty I, Farrington K, Lister Hospital. Stevenage
P126:
BNP, SUITABILITY FOR RENAL TRANSPLANTATION, AND SURVIVAL IN HAEMODIALYSIS
PATIENTS
Sivalingam M, Mathavakkannan S, Farrington K, Lister Hospital, Stevenage
P127:
FEMORAL TUNNELLED DIALYSIS CATHETERS: COMPLICATIONS, OUTCOME AND THE NEED FOR
ROUTINE PROPHYLACTIC ANTICOAGULATION TO PREVENT ASSOCIATED DEEP VEIN THROMBOSIS
Herrington W, Vale T, Barker L, Mohteshamzadeh M, Naik R, Vaux E, Royal
Berkshire NHS Foundation Trust
P128:
CURRENT GUIDELINES FAIL TO PREDICT ONSET OF HAEMODIALYSIS IN THE MAJORITY
Savage T, Weale A, Langdon A, Armitage A, Mitchell D, Southmead Hospital,
Bristol
P129:
SERUM FREE LIGHT CHAIN REMOVAL BY HIGH CUT-OFF HEMODIALYSIS: OPTIMISING REMOVAL
AND SUPPORTIVE CARE
Hutchison C A, Basnayake K, Bradwell A , Cockwell P, University Hospital
Birmingham
P130:
LACK OF ASSOCIATION BETWEEN SERUM CALCIUM LEVEL AND ORAL CALCIUM LOAD IN STABLE
HEMODIALYSIS PATIENTS
Kinsella S, Byrne F, Eustace J A, Cork University Hospital
P131:
DEFINING THE PROCESS TO FOLLOW WHEN A PATIENT DECIDES TO DEVIATE FROM SAFE
PRACTICE
Richardson C, Willis , C, Heart of England NHS Foundation Trust
P132:
THE CORRELATION OF PREDIALYSIS IPTH WITH CHANGE IN PRE AND POST SERUM CALCIUM
IN PATIENT’S HAEMODIALYSED WITH 1.25 MMOL/L CALCIUM DIALYSATE SOLUTION
Magee C, Kinsella S, Byrne F, Plant W D, Eustace J A, Cork University Hospital,
Ireland
P133:
SURVIVAL OF OCTOGENARIANS ON HAEMODIALYSIS: NORTHERN IRELAND PERSPECTIVE
McCarroll F, Xavier A, Hanko J, Shields J McGarrigle M, Mullan R, Kuan Y C,
Northern Ireland Nephrology Forum
P134:
DAILY NOCTURNAL HOME HAEMODIALYSIS (DNHD): DESIRABLE AND DELIVERABLE FOR
BRITISH RENAL PATIENTS
Breen C1,2, Jamieson C1,2 , Gandy D1,
1Guy’s and St Thomas’ NHS Foundation Trust, London, 2Kidney
Disease Modernisation Initiative, London
P135:
REMOVAL OF CARNITINE BY DIALYSATE IN HAEMODIALYSIS (HD) AND PERITONEAL DIALYSIS
(PD) PATIENTS
Stephens F1, Sigrist M1, 2, Owen P1,
2, Constantin-Teodosiu D1, Greenhaff P1,
McIntyre C1, 2, 1University of Nottingham, 2Derby
City General Hospital
P136: SATELLITE UNITS
NEED ADEQUATE PHYSICIAN COVER, VASCULAR ACCESS PROVISION AND EASY ACCESS TO THE
INPATIENT FACILITIES IF PATIENT NUMBERS CONTINUE TO INCREASE
Teo M K4, Patel R S1, Humphreys J A2, Chillal
M2, Bankart J3, Acton S J4, Mistry C D4
1Leicester General Hospital, 2University of Leicester
Medical School, 3Department of Health Sciences, University of
Leicester, 4Peterborough District Hospital
P137:
TOTAL MUSCLE CARNITINE CONTENT, EXERCISE CAPACITY AND CARDIOVASCULAR RESPONSE
TO INTRAVENOUS L-CARNITINE SUPPLEMENTATION IN INCIDENT HAEMODIALYSIS PATIENTS
Owen P1, Stephens F3, Priestman W1, Chesterton
L1, McIntyre C W1 2, 1Derby City
General Hospital, 2School of Graduate Entry Medicine, 3Centre
for Integrated Systems Biology, University of Nottingham
P138:
DEVELOPMENT OF A PODIATRY ASSESSMENT TOOL TO IDENTIFY THE RISK FACTORS FOR FOOT
ULCERATION IN A HAEMODIALYSIS POPULATION
Jones N1, Cawley S1, Phillips A O2, Riley S G2
1Dept of Podiatry, 2Institute of Nephrology, University
Hospital of Wales, Cardiff
P139:
EXAMINING THE ROLE OF THE PHYSIOTHERAPIST ON THE DIALYSIS UNIT
Dentith J1, Smith G2, Steddon S1, Williams A3,
Breen C1
1Guys Hospital 2Modernisation Initiative, London, 3Pembury
Dialysis Unit, Tunbridge Wells.
P140:
USE OF NEUROTHESIOMETER TO ASSESS RISK OF FOOT ULCERATIONS IN HAEMODIALYSIS
PATIENTS
Mullan N, Chrobak L, McDevitt M, Kuan Y, Altnagelvin Area Hospital, Londonderry
Registry & Epidemiology (Moderated session – Friday)
REGISTRY & EPIDEMIOLOGY
P141:
PD PERITONITIS RATES IN SCOTLAND 2002-2007
Mactier R, Simpson K, Scottish Renal Registry and Glasgow Royal Infirmary
P142:
DIALYSIS MODALITY HAS NO EFFECT ON SURVIVAL IN NON-DIABETIC TRANSPLANT LISTED
PATIENTS
Thomson P C, Traynor J P, Simpson K, Mactier R A, On behalf of the Scottish
Renal Registry
P143:
FACTORS THAT DETERMINE THE 1-YEAR SURVIVAL OF PATIENTS STARTING DIALYSIS IN A
DISTRICT GENERAL HOSPITAL RENAL UNIT: A 7 YEAR RETROSPECTIVE SURVIVAL ANALYSIS
Roberts N1, Williams A1, Kumwenda M1, 1Glan
Clwyd Hospital, Bodelwyddan, North Wales
P144:
IS MILD KIDNEY DISEASE AN INDEPENDENT RISK FACTOR FOR MORTALITY? FINDINGS FROM
THE GRAMPIAN CKD STUDY GROUP
Clark L1, Prescott G2, Smith C2, Fluck N3,
Simpson W4, MacLeod A1
1Medicine and Therapeutics and2Public Health, University
of Aberdeen3Renal Unit, NHS Grampian, Aberdeen, 4Clinical Biochemistry, NHS
Grampian, Aberdeen
P145:
LESSONS FROM THE STUDY OF A LONGITUDINAL AUDIT OF OUTCOMES FOR A BIOLOGICAL
VARIABLE IN HAEMODIALYSIS
Jones C, Richardson D Will E, York Hospital
P146:
THE KIDNEY EVALUATION OF OBESE POPULATION OF SHEFFIELD (KEOPS) STUDY:
PREVALENCE OF MICROALBUMINURIA IN A COHORT OF NON-DIABETIC OVERWEIGHT AND OBESE
RESIDENTS OF SHEFFIELD
Kawar B1, El Nahas M1, Goyder E2, Skinner J3,
1Sheffield Kidney Institute, 2 University of Sheffield,
3Sheffield West Primary Care Trust
P147:
THE EPIDEMIOLOGY OF PRIMARY GLOMERULONEPHRITIS IN NORTHERN IRELAND OVER 30
YEARS
J Hanko, J1, Mullan R2, O’Rourke D1, McNamee P1,
1Belfast City Hospital, 2Antrim Area Hospital McNamee
P148:
VARIATION BETWEEN DIALYSIS CENTRE ACHIEVEMENT OF AUDIT MEASURES FOR SERUM
PHOSPHATE. DATA FROM UK RENAL REGISTRY
Hodsman A1, Gilg J1, Ben-Shlomo Y2, Roderick P3,
Ansell D1, Tomson C1
1UK Renal Registry, Bristol, 2 University of Bristol, 3
University of Southampton
P149:
IS UNIT PERFORMANCE FOR ACHIEVEMENT OF THE PHOSPHATE CLINICAL PRACTICE
GUIDELINE A STABLE CHARACTERISTIC OVER TIME? DATA FROM UK RENAL REGISTRY
Hodsman A1, Gilg J1, Ben-Shlomo Y2, Roderick P3,
Ansell, D1 Tomson C1
1UK Renal Registry, Bristol, 2 University of Bristol, 3
University of Southampton
P150:
SURVIVAL ON DIALYSIS IN SOUTH EAST SCOTLAND
Lajili FA, Turner AN, Metcalfe W, UNIVERSITY OF EDINBURGH
P151:
ANCA- ASSOCIATED SYSTEMIC VASCULITIS IN NORTH CUMBRIA
Teliki R, Mead P A, Kuppers B, Cumberland Infirmary, Carlisle
P152:
RENAL REPLACEMENT THERAPY AND MALIGNANCY – WHO IS AT HIGHEST RISK?
A COLLABORATIVE STUDY BETWEEN THE SCOTTISH RENAL REGISTRY (SRR) AND THE
SCOTTISH CANCER REGISTRY (SCR)
Fraser E1, Brewster D2, Junor B1, Simpson K1,
1Scottish Renal Registry Glasgow Royal Infirmary, 2Scottish
Cancer Registry, Edinburgh
P153:
INCIDENCE OF BIOPSY PROVEN PAUCIIMMUNE NECROTISING/CRESCENTIC
GLOMERULONEPHRITIS IN GREATER MANCHESTER
Dhaygude A P1 2, Bruce I2, Clarke A3,
O’Donoghue D1, Harris S2, Kalra P1, Venning M2,
Brenchley P2
1Hope Hospital, Salford, 2Manchester Royal Infirmary, 3Manchester
and Arc Epidemiology Unit
P154: VALIDITY OF
THE MDRD ESTIMATED GFR AT 1 YEAR V CREATININE AS A MARKER OF TRANSPLANT OUTCOME
IN 4,628 KIDNEY TRANSPLANT RECIPIENTS
Ford D, Casula A, Ansell D, Ravanan R, UK Renal Registry
P155: RENAL
TRANSPLANTATION IS NOT ASSOCIATED WITH SIGNIFICANT REGRESSION OF LEFT
VENTRICULAR HYPERTROPHY ON CARDIAC MRI
Mark P B1, Johnson N2, Dargie H J2, Jardine A
G1, 1University of Glasgow, 2Western
Infirmary, Glasgow
P156: KAPOSI’S
SARCOMA IN BLACK AFRICAN TRANSPLANT PATIENTS
Trevitt R, Dobbie H, Barts and the London NHS Trust
P157: ACTIVITY OF
MITOCHONDRIAL COMPLEXES IN CADAVERIC RENAL GRAFTS, COLD ISCHAEMIA TIME AND
SUBSEQUENT RECOVERY OF GRAFT FUNCTION
Kubal C1, Harris R3, Inston N1, Graetz K1,
Ready A1, Mellor S1, Hamsho A1, Waring R3,
World MJ1, 2, 4.
1Queen Elizabeth Hospital, Birmingham, 2Queen Elizabeth
Hospital, Birmingham
3University of Birmingham, 4Royal Centre for Defence
Medicine, Birmingham
P158: THE
INCIDENCE OF COMPLICATIONS AND GRAFT SURVIVAL IN PATIENTS TRANSPLANTED OUTSIDE
UK
Arsalanizadeh B1, Judge P1, Bankart J2,
Medcalf J1, Carr S1, 1Leicester General
Hospital, 2University of Leicester
P159:
TRANSPLANT WAITLISTING DURING FIRST TWO YEARS ON HAEMODIALYSIS (HD) IN THE
DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS): PREDICTORS AND
COMPARISONS BETWEEN THE UK AND EUROPE
Stringer S⁵, Poler K1, Pisoni R1, Robinson B1,
Greenwood R2, Fluck R3, O’Donoghue D4, Rayner
H⁵
1Arbor Research for Collaborative Health, Michagan, USA, 2Lister
Hospital, Stevenage, 3Derby Hospitals NHS Foundation Trust, 4
Salford Hospital NHS Trust, ⁵Heart of England NHS Foundation Trust
P160: MINIMALIST
IMMUNOSUPPRESSION IN RENAL TRANSPLANTATION: CAMPATH AND TACROLIMUS MONOTHERAPY
3 YEAR RESULTS
Chan K, Galliford J, Betmouni R, McLean A, Dorling A, Duncan N, Hakim N,
Palme A, Papalois V, Warrens A, Taube D, Hammersmith Hospital, London
P161: RANDOMISED
CONTROLLED TRIAL OF CAMPATH AND TACROLIMUS-MONOTHERAPY WITH DACLIZUMAB,
TACROLIMUS AND MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION; INTERIM RESULTS
Chan K, Taube D, Galliford J, Charif R, Dorling A, Goodall D, Hakim N,
Palmer A, Papalois V, Warrens A, McLean A, Hammersmith Hospital, London
TRANSPLANTATION 2 (Moderated session – Friday)
P162: CAMPATH
INDUCTION & TACROLIMUS MONOTHERAPY IN SIMULTANEOUS KIDNEY & PANCREAS
TRANSPLANTATION
Charif R, West London Renal & Transplant Centre, Hammersmith Hospital
P163: REVIEW
OF BK NEPHROPATHY PRESENTING AFTER 12 MONTHS POST TRANSPLANTATION IN 2 NON
TRANSPLANT UNITS
Ponnusamy A1,Redshaw J1,Follows G1Hegarty J1,Solomon
, LR2
1Salford Royal Foundation Trust, 2Lancashire Teaching
Hospitals Foundation NHS Trust,Preston
P164: PREVALENCE
OF ALL MALIGNANCIES IN RENAL TRANSPLANT RECIPIENTS – 10 YEARS FOLLOW UP
Suresh V, Richardson C, Dasgupta A I, Birmingham Heartlands Hospital
P165: RENAL
TRANSPLANTATION AND CALCINEURIN INHIBITOR WITHDRAWAL OR MINIMISATION IN
COMBINATION WITH MYCOPHENOLATE: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
Moore J1 , Middleton L2, Cockwell P1, Wheatley
K2, Borrows R1, 1University Hospital
Birmingham, 2University Of Birmingham
P166: THE EFFECT OF
INTRAVENOUS IRON ON RENAL FUNCTION IN RENAL TRANSPLANT PATIENTS
Pile T, Dunsmore V, Raftery M, Yaqoob M M, Barts and the London NHS Trust
P167: SINGLE CENTRE
EXPERIENCE OF POST TRANSPLANT DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) TREATED
WITH IMMUNO-CHEMOTHERAPY (CHOP-R)
Chan G1, Tulpule S2, Fields P2, Goldsmith D1,
Renal1, Haematology2, Units Guy’s and St Thomas’ NHS
Foundation Trust, London
P168: BK
NEPHROPATHY
Hunter C E1, Sinnamon K T O1, O’Rourke D 1,
Coyle P V2, Brown J H1, 1 Belfast City
Hospital, 2Royal Victoria Hospital.
P169: POOR ONE
YEAR OUTCOMES FOR KIDNEY TRANSPLANT ‘TOURISTS’ FROM THE WEST MIDLANDS
Krishnan N1, Cockwell P2, Devulapally P3,
Gerbe B1, Hanvesak R2, Higgin R3, Ready A2,
Carmichae P4, Kumar S⁶, Dasgupta I1
1Heartlands Hospital, 2University Hospital Birmingham, 3Walsgrave
Hospital, Coventry, 4Royal Wolverhampton Hospitals, ⁵North
Staffordshire Hospitals, ⁶Dudley Hospitals
P170: RENAL
TRANSPLANTATION IN SYSTEMIC VASCULITIS: WHEN IS IT SAFE?
Little M1, Hassan B1, Jacques S1, Game D2,
Salisbury E2, Courtney A3, Brown C4, Salama A1,
Harper L1
1University of Birmingham, 2Hammersmith Hospital, London,
3Belfast City Hospital, 4Beaumont Hospital, Dublin
ANAEMIA
P171:
MINIMISING Hb VARIATION IN PREDIALYSIS PATIENTS: WHICH ESA TO CHOOSE?
McCafferty K*1, Pile T1, Byrne C1, Varagunam M1,
Birbeck S1, Rafter, M1 , Yaqo, M1. 1Nephrology,
Barts and the London NHS Trust, London,
P172: SAFETY AND
EFFICACY OF ERYTHROPOESIS STIMULATING AGENTS (ESA) FOR TREATMENT OF ANAEMIA IN
PREGNANCY OF WOMEN WITH CHRONIC KIDNEY DISEASE (CKD)
Ferraro A J1, Sheikh L2, Nair H1, Kilby M2,
Carr S J3, Lipkin G1
1 University Hospital, Birmingham, 2 Birmingham Women’s
Hospital, 3 University Hospital Leicester.
P173: THE
INTRODUCTION OF A SHARED CARE PROTOCOL FOR THE MANAGEMENT OF RENAL ANAEMIA IN A
GENERAL NEPHROLOGY SETTING
Cheung C K, Stoves, J, Ott J, Coman T, Akbani H, Jeffrey R, Roberts R,
Bradford Teaching Hospitals NHS Trust
P174:
SHIFTING A Hb DISTRIBUTION: USE OF CLINICAL DECISION SUPPORT ENGINE TO IMPROVE
COMPLIANCE WITH THE RENAL ASSOCIATION GUIDELINES
Richardson R, Jones C H, York Hospitals NHS Foundation Trust
P175:
SELF-ADMINISTRATION OF IV IRON SUCROSE FOR HOME HAEMODIALYSIS PATIENTS IMPROVES
ANAEMIA MANAGEMENT
Lean M, McKane W, Sheffield Kidney Institute
P176: THE EFFECT OF
DIABETES ON ERYTHROPOETIN STIMULATING AGENT DOSE REQUIREMENTS IN CHRONIC KIDNEY
DISEASE
Pile, T, McCafferty, K, Byrne, C, Varagunam, M, Yaqoob, M M, Barts and the
London NHS Trust
P177: USE OF
INTRAVENOUS IRON FOR ANAEMIA MANAGEMENT IN LOW CLEARANCE PATIENTS
Sloan, L, Borthwick, E, Cunningham, R, Mullan, R, Harron, C, Antrim Area
Hospital, Northern Ireland
P178: THE EFFECT
OF A DIRECT SWITCH, MAINTAINING FREQUENCY AND ROUTE OF ADMINISTRATION, FROM
DARBEPOETIN Α TO EPOETIN Α ON HAEMOGLOBIN CONCENTRATION IN A STABLE
HAEMODIALYSIS POPULATION
Jones M, Krishnakumar S, Matijevic Almond M, Southend Hospital
P179:
MOTALITY IN NON-DIALYSED CKD PATIENTS AND ITS RELATIONSHIP TO ANAEMIA
MANAGEMENT
Balshaw-Greer A, Delaney J, McClelland P, Wirral University Teaching Hospital
PERITONEAL DIALYSIS
P180: DIALYSATE
PROTEIN CLEARANCE, NOT RAPID TRANSPORT STATUS IS ASSOCIATED WITH REDUCED
SURVIVAL IN A CONTEMPORARY COHORT OF PERITONEAL DIALYSIS PATIENTS
Perl J1, Huckvale K2, Chellar M2, John B2,
Davie, S J2
1. University Health Network, Toronto, Canada, 2.
University Hospital of North Staffordshire, and Keele University
P181:
IMPACT OF EXTRANEALTM DAY DWELLS ON PHOSPHATE CLEARANCE DURING PAEDIATRIC
PERITONEAL DIALYSIS
Daljit Hothi D, Cantwell M, Rees L, Bockenhauer D, Great Ormond Street Hospital
for Children NHS Trust
P182: A NATIONAL
SURVEY OF PERITONEAL DIALYSIS ACCESS
Wilkie M1, Wild J2, 1Sheffield Teaching
Hospitals NHS Trust, 2Baxter Healthcare UK.
P183: HAEMOGLOBIN
CYCLING OCCURS IN PERITONEAL DIALYSIS PATIENTS AND IS ASSOCIATED WITH
ERYTHROPOIETIN TREATMENT AND DOSE CHANGES
Selby, N M, Taal, M W, Johnson, C, Fluck, R J, Derby City Hospital
P184: MODERATE
SYSTEMIC INFLAMMATION IS NOT CORRELATED TO AN INCREASED VASCULAR PROTEIN LEAK
IN PD PATIENTS
John B, Davies S J, University Hospital of North Staffordshire
P185: PERITONEAL
DIALYSIS CATHETER INSERTION USING TROCAR METHOD BY NEPHROLOGIST - AN AUDIT ON
SUCCESS AND SAFETY
Ahmed, M S, Saligram, S, Anijeet, H, Royal Liverpool University Hospital
P186: KT/V
OVERESTIMATES PERITONEAL DIALYSIS DOSE IN WOMEN.
Lawrence C, Jolly EC, Doyle S, Chandna SM, Farrington K, Lister Hospital,
Stevenage
P187: GLOBAL
ADEQUACY SCORE PREDICTS OUTCOME IN PERITONEAL DIALYSIS PATIENTS
Jolly E, Hollis J, Williams P, Addenbrooke’s Hospital, Cambridge
P188:
LONG-ACTING ANTIMICROBIAL BIOMATERIAL FOR PERITONEAL DIALYSIS CATHETERS
Bayston R1, Fisher L1, Fluck R2, McIntyre C1
2, 1University of Nottingham, 2Derby City
General Hospital
P189: HOSPITAL
ANXIETY AND DEPRESSION SCORES AND THE RISK OF DEATH, TECHNIQUE FAILURE, AND
PERITONITIS IN AN INCIDENT COHORT OF PERITONEAL DIALYSIS PATIENTS
Chellar M1, Perl J2, Huckvale K1, John B1,
Davies S J1
1. University Hospital of North Staffordshire and Keele University, 2.
University Health Network, Toronto, Canada
P190: HAEMOGLOBIN
VARIABILITY IN PERITONEAL DIALYSIS (PD) PATIENTS: DOES TYPE OF ESA MATTER?
Byrne C J, Pile T, McCafferty K, Varagunam M, Fan S, Raftery M J, Yaqoob M M,
Barts and the London NHS Trust, London
P191: EVIDENCE
THAT CT SCANS CAN INFLUENCE CLINICAL MANAGEMENT OF ENCAPSULATING PERITONEAL
SCLEROSIS
Hurst H, Augustine T, Taylor I, Hutchison A J, Dunn L, Brenchley P, E de
Freitas, D, Summers A M
Manchester Royal Infirmary
PSYCHOSOCIAL ASPECTS
P192: PAINTING ON
DIALYSIS – A PILOT EVALUATION HAS BEEN SUBMITTED AND RECORDED IN OUR DATABASE
Jones C, Seeger L, Holman C, York Hospital, Renal Unit
P193: THE PERSONAL
KIDNEY MANAGEMENT HANDBOOK: A TOOL TO SUPPORT EMPOWERMENT OF PEOPLE WITH CKD
AND ENCOURAGE PARTNERSHIP IN DECISION MAKING
Short H, Leicester General Hospital
P194: SCREENING
FOR DEPRESSION WHILE PATIENTS DIALYSE - AN EVALUATION.
Chilcot J1 2, Farrington K,1 & Wellsted DM2,
1Lister Hospital Stevenage
2The Centre for Lifespan and Chronic Illness Research (CLiCIR)
University of Hertfordshire
P195: QUALITY OF
HEALTH OF HAEMODIALYSIS PATIENTS IN NORTH CUMBRIA
Teliki R, Khalil Khan H, Mead P A, Cumberland Infirmary, Carlisle.
P196: RECOGNISING
AND VALUING CARERS: THE CREATION OF A LEAFLET
Holman C, York Hospital
P197: STAYING IN
WORK WITH A DIAGNOSIS OF RENAL FAILURE: EMPOWERING PATIENTS THROUGH INFORMATION
Cosquer C, York Hospital
P198: PRE
TREATMENT INFORMATION AND EDUCATION – WHAT DO PATIENTS REALLY WANT?
Tibbles, R1, Smith, G1, Cox, S2, Wood, E3,
Vinen, K3, 1Modernisation Initiative, London, 2Guy’s and
St Thomas’ NHS Foundation Trust, 3King’s College Hospital NHS Foundation Trust,
London
P199:
BROADENING OPTIONS FOR LONG TERM DIALYSIS IN THE ELDERLY STUDY (BOLDE)
Johansson, L1, Beckett, N1, Clemenger, M2,
Dasilva Gane, M3, Duncan, N2, Farrington, K3,
Gallagher, H4, Sensky, T1, Singh, S K2, Brown,
E A2, 1Imperial College, London2West London
Renal & Transplant Centre (Imperial College Healthcare NHS Trust), 3Lister
Hospital (East and North Hertfordshire NHS Trust)
4St Helier Hospital (Epsom and St Helier University Hospitals NHS Trust)
P200: DEPRESSION
AND ILLNESS REPRESENTATIONS AMONG THE DIALYSIS POPULATION. STUDY OVERVIEW AND
PROGRESS
Chilcot J1 2, Wellsted DM2, Firth J3,
Davenport A4, Farrington K1
1Lister Hospital, Stevenage, 2The Centre for Lifespan and
Chronic Illness Research (CLiCIR), University of Hertfordshire, 3Addenbrooke’s
Hospital, Cambridge, 4Royal Free Hospital, London
P201:
RENAL-SPECIFIC VS. STANDARD ORAL NUTRITIONAL SUPPLEMENTS IN HAEMODIALYSIS
PATIENTS
Williams R F, Summers A, Manchester Royal Infirmary
P202: AUDIT OF
NUTRITIONAL STATUS OF PATIENTS STARTING RENAL DIALYSIS
Wallace L, Hull Royal Infirmary
P203:
PHYSICIANS AND DIETITIANS HOLD WIDELY DIFFERING PERCEPTIONS OF THE NUTRITIONAL
STATUS OF ACUTE RENAL INPATIENTS
El-Sherbini N, Dassanayake T, De Naurois J, Choi P, West London Renal
Transplant Centre
P204: THE
EFFECT OF AN ACUTE, PHYSIOLOGICALLY RELEVANT, INCREASE IN SALT INTAKE ON PLASMA
SODIUM
Suckling R J, He F, MacGregor G, St George’s University of London
P205: THE
INTRODUCTION OF A NUTRITION LINK NURSE PROGRAMME
Underwood S, Thomsett K, Kent and Canterbury Hospital
P206: IS IT
POSSIBLE FOR PATIENTS TO IMPROVE HYPERPHOSPHATAEMIA CONTROL BY SELF MANAGEMENT?
Green, D, Gregson, Butler E, Hegarty J, Salford Royal Foundation Trust
P207: DIETITIANS
VS CLINICIANS IN CALCIUM PHOSPHATE MANAGEMENT - RESULTS OF A REGIONAL AUDIT!
Martin J, Fallouh B, Dasgupta I, Birmingham Heartlands Hospital
P208: IDPN – A
USEFUL NUTRITIONAL TOOL FOR THOSE HAEMODIALYSIS PATIENTS WITH SHORT BOWEL
SYNDROME AND CHRONIC MALABSORPTION – CASE STUDY
Kennedy S C, Parry R, Royal Cornwall Hospital
P209: USING A
MULTIDISCIPLINARY APPROACH FOR WEIGHT LOSS IN RENAL PATIENTS
Jeffreys E1, Dentith J E1, Mudenda L1, Smith G2,
Breen C1, 1 Guys Hospital, 2Modernisation
Initiative, London
P210: DIETETIC
MANAGEMENT OF PHOSPHATE BINDER MEDICATION SUSTAINS LONGER TERM IMPROVEMENT OF
BONE BIOCHEMISTRY IN HOSPITAL-BASED HAEMODIALYSIS PATIENTS
Hartley G H, Murray M, Lockwood V, Rai E M, Brown A L, Kanagasundaram N S
The Freeman Hospital, Newcastle upon Tyne
P211:
INTRADIALYTIC PARENTERAL NUTRTION AS A FORM OF NUTRITION SUPPORT: A 5 YEAR
REVIEW
Calder J M, Greaves E J, Wright M J, Leeds Teaching Hospitals NHS Trust
P212: VARIATION
IN RESPONSE TO CINACALCET IN DIALYSIS PATIENTS WITH HYPERCALCEMIA AND
HYPERPARATHYROIDISM
Lindley E, Rahman N, Woodrow G, Wright M, Will E
Department of Renal Medicine, Leeds Teaching Hospitals NHS Trust, Leeds
P213: IS EARLY
MEASUREMENT OF PARATHYROID HORMONE LEVELS A USEFUL TOOL FOR PREDICTING
INCOMPLETE SURGICAL EXCISION IN RENAL PATIENTS UNDERGOING ELECTIVE
PARATHYROIDECTOMY?
Lines S W, England J, Bhandari S, Department of Renal Medicine, Hull and East
Yorkshire Hospitals NHS Trust,
P214: VITAMIN
D INSUFFICIENCY IS COMMON IN CAUCASIANS WITH CKD STAGE 3: A TWO CENTRE, URBAN
AND RURAL STUDY
Mappleback, S1, Harnett, P R1, Moro-Azuela, F1,
Carmichael, D1, Ashman, N2, Almond, M K1
1Southend University Hospital, 2Barts and the London NHS
Trust
P215: CINACALCET
RESULTS IN EFFECTIVE AND CLINICALLY SIGNIFICANT REDUCTIONS IN PTH: RESULTS IN
62 PATIENTS FROM A SINGLE DIALYSIS UNIT
Symes F, Chesterton LI, Kohle NV, Leung J, Taal MW, McIntyre CW and Fluck
RJ, Derby City General Hospital
P216:
PARATHYROIDECTOMY OUTCOME IN THE RENAL REPLACEMENT (RRT) POPULATION: THE
SHEFFIELD EXPERIENCE
Ahmed, A1, Fotheringham, J1, Mohammed, A1,
Harrison, B2, Wilkie, M1
1Sheffield Kidney Institute, 2Royal Hallamshire Hospital,
Sheffield
P217:
CALCIUM-SENSING RECEPTOR GENE POLYMORPHISM ARG990GLY INFLUENCES THE RESPONSE TO
CALCIMIMETIC AGENTS
Rothe H, Klinikum Neumarkt, Germany
P218: GENETIC
MAKEUP OF CALCIUM-SENSING RECEPTOR GENE POLYMORPHIC POSITION 990 AND PARAMETERS
OF SECONDARY HYPERPARATHYROIDISM
Rothe H, Klinikum Neumarkt, Germany
P219:
CINACALCET IN SCOTLAND: THE FIRST THOUSAND DAYS
MacGregor, M S1, Currie, A D1, Mactier, R A2,
Henderson, I S3, Jenkins, D A S4, Dimova, M G 5, Lambie, S H6, Almond, A L7. 1Crosshouse
Hospital, Kilmarnock, 2Western and Royal Infirmaries, Glasgow 3Ninewells
Hospital, Dundee, 4Queen Margaret Hospital, Dunfermline, Royal
Infirmary, Edinburgh, Raigmore Hospital, Inverness, Dumfries & Galloway
Royal Infirmary
P220:
RELATIONSHIP BETWEEN SERUM PARATHYROID HORMONE CONCENTRATIONS (PTH) AND 25 (OH)
VITAMIN D AND BONE MINERAL DENSITY (BMD) IN PATIENTS WITH PRE-DIALYSIS CKD.
Manghat P1, Asgari E2, Fogelman I 3, Wierzbicki AS 1,
Hampson GN1 and Goldsmith DJA2
Department of Chemical Pathology1, Renal Unit2,
Osteoporosis Screening Unit3 Guy’s Hospital, London
P221:
INDEPENDENT ASSOCIATION OF EGFR WITH FRACTURE OCCURRENCE AMONG FEMALE DEXA
SUBJECTS
Kinsella S, Moran S, Chavrimootoo S, Molloy M G, Eustace J A, Cork
University Hospital
P222: A PILOT
STUDY OF INTRAVENOUS 1-ALPHACALCIDOL IN THE TREATMENT OF HYPERPARATHYROIDISM
REFRACTORY TO ORAL MEDICATION IN PATIENTS ON REGULAR HAEMODIALYSIS THERAPY
Rahman, T1, Chapman, E1, MJ World, M J 1 2,
1City Hospital, Birmingham, 2Selly Oak Hospital,
Birmingham
P223: EARLY
EFFECTS OF PARICALCITOL THERAPY ON SERUM CALCIUM, PHOSPHATE AND
CALCIUM-PHOSPHATE PRODUCT IN HAEMODIALYSIS PATIENTS
Rahim Y A, Elamin W, Hannan K, Cavan General Hospital, Ireland
P224:
BISPHOSPHONATE PRESCRIBING GUIDELINES – IS EVERYONE A LOSER?
McCloskey M C, Smyth J, MarshallW, Leonard N, Renal Unit, Ulster Hospital
P225: CIRCULATING
PARATHYROID HORMONE (PTH) LEVELS DO NOT CORRELATE WITH MEASURED BONE COLLAGEN
FORMATION RATE IN PREVALENT MALE HAEMODIALYSIS PATIENTS
Owen P, Priestman W, McIntyre C, Derby City Hospital
P226: IS
LANTHANUM AN EFFECTIVE PHOSPHATE BINDER?
MacGregor M S1, Currie AD1, Midwinter F J2,
Clark J M2, Oun H2, Velasco N1, Innes A1,
MacKay I G1, Traynor JP2. 1Crosshouse
Hospital, Kilmarnock, 2Monklands Hospital, Airdrie
P227:
HAEMODIALYSIS INDUCED MYOCARDIAL DYSFUNCTION IS ASSOCIATED WITH INCREASED
INCIDENCE OF INTRADIALYTIC VENTRICULAR ECTOPY
Burton JO 1, Korsheed S 1, Grundy BJ 2,
McIntyre CW 1,3. 1 Derby City General Hospital. 2 Department
of Clinical Measurement, Derby City General Hospital 3 University of Nottingham
P228:
ULTRAFILTRATION VOLUME IS AN INDEPENDENT RISK FACTOR FOR MYOCARDIAL STUNNING IN
HAEMODIALYSIS PATIENTS
Burton JO 1, Korsheed S 1, Jefferies HJ 1,
McIntyre CW 1,2, 1 Derby City General Hospital
2 University of Nottingham
P229: FREE
TRIIODOTHYRONINE LEVEL IS NOT ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY, THE
DEVELOPMENT OF ACUTE HAEMODIALYSIS-INDUCED CARDIAC INJURY OR SURVIVAL
Jefferies H1 ,2, Burton J1,2,
O’Sullivan S1, McIntyre C1,2, 1University
of Nottingham, 2Derby City General Hospital
P230: ACUTE
HAEMODIALYSIS-INDUCED CARDIAC INJURY AND SUBSEQUENT INCREASED MORTALITY IS
ASSOCIATED WITH SYSTEMIC INFLAMMATION
Jefferies H1,2, Burton J1,2,
O’Sullivan S1, McIntyre C1,2, 1University
of Nottingham.
2Derby City General Hospital
P231:
N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IS A POTENTIAL BIOMARKER OF
HAEMODIALYSIS-INDUCED ACUTE CARDIAC INJURY (MYOCARDIAL STUNNING)
Jefferies, H1 2, Burton, J1,2,
O’Sullivan, S1, McIntyre, C1,2, 1University
of Nottingham, 2Derby City General Hospital
P232: FACTORS
AFFECTING PROGRESSION OF ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE IN AN
OUT-PATIENT SETTING
Sinha, S, Eddington,H, Hegarty,J, Lane, B, Foley, R1, O’Donoghue,D ,
Kalra, R A, Salford Royal Hospital Foundation Trust, 1Chronic
Disease Research Group and Department of Medicine, University of Minnesota, US
P233:
DETERMINANTS Of Arterial Stiffness And Endothelial Dysfunction In Chronic
Kidney Disease
Lilitkarntakul P, Dhaun N, Melville V, Goddard J, Webb D, University of
Edinburgh
P234: VITAMIN D
HAS A BIMODAL EFFECT ON VASCULAR STRUCTURE AND CALCIFICATION IN CHILDREN ON
DIALYSIS: CALCIUM-PHOSPHATE HOMEOSTASIS AND BEYOND
Shroff, R1 3, Egerton, M2, Bridel, M2,
Shah, V1, Donald, A E3, Cole, T J4, Hiorns M
P⁵, Deanfield J E3, Rees, L1 1 ⁵Great Ormand
Street Hospital for Children, 2West Park hospital, Epsom, 3
4UCL Institute for Child Health
P235: BAROREFLEX
SENSITIVITY PROGRESSIVELY DETERIORATES IN CHRONIC KIDNEY DISEASE
John S1, Sigrist M1, Taal M1, McIntyre C1,2,
1Derby City General Hospital, 2 University of Nottingham
P236: BAROREFLEX
SENSITIVITY IS NOT REDUCED BY ANTIHYPERTENSIVE THERAPY IN OLDER PEOPLE WITH
CHRONIC KIDNEY DISEASE
John S1, Owen P1, Youde J2, Taal M1,
McIntyre C1, 3 1Derby City General Hospital, 2Derbyshire
Royal Infirmary, 3University of Nottingham
P237: IMPAIRED
BAROREFLEX SENSITIVITY PREDICTS MORTALITY IN CHRONIC KIDNEY DISEASE
John S1, Sigrist M1, Chesterton L1, McIntyre C1,2,
1Derby City General Hospital, 2University of Nottingham
P238: TISSUE
ADVANCED GLYCATION END PRODUCT CONCENTRATION IN HAEMODIALYSIS PATIENTS
John S1, Jefferies H1, Owen P1, Burton J1,
McIntyre N1, Fluck R1 , McIntyre C1,2.
1 Derby City General Hospital, 2 University of Nottingham
P239: A NOVEL
TECHNIQUE FOR ASSESSMENT OF ARTERIAL STIFFNESS IN CKD
Wilmink T, Ferring M, Claridge M, Bates G, Fallouh B Dasgupta I, Heartlands
Hospital, Birmingham
P240:
AMBULATORY ASSESSMENTS OF AORTIC STIFFNESS IN A COHORT OF SUBJECTS WITH CKD 3
AND 4
Tomlinson L A, Ford M, Leslie A R, Kingswood J C, Holt S G, Rajkumar, C,
Brighton and Sussex Medical School
ACUTE KIDNEY INJURY
P241:
EPIDEMIOLOGY OF ACUTE KIDNEY INJURY WITHIN CORNWALL: ONE YEAR PROSPECTIVE STUDY
Wallace K R, Andain K, Johnston P A Stratton J D, Parry R G, Royal Cornwall
Hospital
P242: ACUTE
KIDNEY INJURY STAGING FOLLOWING CARDIOTHORACIC SURGERY PREDICTS THE NEED FOR
RENAL REPLACEMENT THERAPY AND LENGTH OF HOSPITAL STAY
Gone. K1, Javangula, K2, Kay, P2, Lewington, A
J P1, 1St James University Hospital, 2Cardiothoracic
Surgery, Leeds
P243: THE
INCIDENCE OF ACUTE KIDNEY INJURY ASSOCIATED WITH GADOLINIUM USE IN MILD CHRONIC
KIDNEY DISEASE
Sinnott C1, Craddock A2, Murray J2, Sadlier D
M1, O’ Meara Y M1
Department of Nephrology1 and Radiology2, Mater
Misericordiae University Hospital, Dublin, Ireland
P244: ACUTE
KIDNEY INJURY (AKI) IN ADULTS – WHO IS REFERRED AND WHO IS NOT REFERRED? A
SYSTEM WIDE AUDIT
Thomas M, Manji T, Hatton C, Willis C, Baharani J, Birmingham Heartlands
Hospital
P245: HIGH
RATES OF RENAL RECOVERY AND PATIENT SURVIVAL IN MYELOMA KIDNEY USING FREE LIGHT
CHAIN REMOVAL HEMODIALYSIS
Hutchison, C A, Basnayake, K, Cook, M, Bradwell, A, Cockwell, P, University
Hospital Birmingham
P246: SUB-OPTIMAL
DELIVERY OF RENAL ASPECTS OF CARE AFTER STEP-DOWN FROM CRITICAL CARE TO
NON-SPECIALIST WARDS
Hardy, T J1, Rhodes, A L1, Kaudeer, N1,
Wright, S E2, Baudouin, S V2,3, Kanagasundaram, N S1
1Freeman Hospital, Newcastle-upon-Tyne, 2Royal Victoria
Infirmary, Newcastle upon Tyne
3North East and Cumbria Critical Care Network
P247: ACUTE KIDNEY
INJURY – A TEN YEAR OUTCOME STUDY
Kolhe N1, Klebe B2, Al Hasani M2, Stevens P2,
1Derby City Hospital, 2Kent and Canterbury Hospital
P248: OLIGURIA –
PREDICTOR OF LONG TERM MORTALITY IN ACUTE KIDNEY INJURY
Kolhe N1, Klebe B2, Al Hasani M2, Stevens P2
1Derby City Hospital, 2Kent and Canterbury Hospital
P249: OUTCOMES
ASSOCIATED WITH PRIMARY RENAL DISEASE AND CRITICAL CARE ADMISSION
Jones SL, Roe SD, Nottingham University Hospitals NHS Trust
P250: AUDIT OF
OUTCOMES OF PATIENTS TRANSFERRED FROM NEPHROLOGY WARDS TO A UNIVERSITY HOSPITAL
ICU
Judge P K, Al-Jayyousi R , Leicester General Hospital
GLOMERULAR DISEASE
P256: ANCA
STATUS AND PROGNOSIS IN RENAL VASCULITIS
Stevens K, McManus S K, Mark P B, Fox J G, Stirling C, Glasgow Royal Infirmary
P257: A
SINGLE RENAL UNIT’S EXPERIENCE OF USING RITUXIMAB IN THE MANAGEMENT OF LUPUS
NEPHRITIS AND ANCA ASSOCIATED VASCULITIS USING A DOSING TO TARGET APPROACH
Stolagiewicz N E, Rigby S, Willicombe M, Burns A , Royal Free and
University College Medical School, London
P258: PRESCRIPTIVE
AND TREATMENT PROTOCOLS FOR THERAPEUTIC PLASMA EXCHANGE – A BENCHMARKING
EXERCISE
Weir D, Kent and Canterbury Hospital
P259:
STEROID-LIMITED RITUXIMAB RESCUE THERAPY FOR LUPUS NEPHRITIS - 12 MONTH FOLLOW
UP
Kirwan C, Lightstone L, Pepper R J, Griffith M, Levy J, Taube D, Pusey C D,
Cairns T, Hammersmith Hospital, London
P260:
RELAPSING NEPHROTIC SYNDROME SUCCESSFULLY TREATED WITH RITUXIMAB –A CRITICAL
SYNERGISTIC REQUIREMENT FOR STEROIDS
Gunatillake N, Gaskin G, Cairns T, Loucaidou M, Pusey C, Salama,
Imperial College Kidney and Transplant Institute, Hammersmith Hospital, London
P261: WEGENER’S
GRANULOMATOSIS AND PROLIFERATIVE LUPUS NEPHRITIS – SAME TREATMENT PROTOCOLS,
DIFFERENT INFECTION PROFILE
Morton M, Edmonds S, Doherty A M, Parsons D, Dhaygude A, Helbert M, Venning M
Manchester Royal Infirmary
VASCULAR & INFLAMMATORY BIOLOGY
P262:
STREPTOCOCCUS PNEUMONIAE –INDUCED HAEMOLYTIC URAEMIC SYNDROME: ACQUIRED
COMPLEMENT DYSREGULATION?
Johnson, S A1, Williams, J M1, Satchell, S C2,
Savage, C O S1 Taylor, C M3.
1 University of Birmingham, 2 Southmead Hospital,
Bristol, 3 Birmingham Children’s Hospital
P263 EFFECT OF
SERINE PROTEASES, ELASTASE AND PR3 ON GLOMERULAR EC-NEUTROPHIL INTERACTIONS
Tull S1, Panchagnula S1, Bevins A1, Satchell S
C, 3, Harper L1, Rainger G E2, Savage C1
1Renal Immunobiology, and 2Department of Physiology,
University of Birmingham, 3University of Bristol, Southmead Hospital
P264: EFFECT OF
ANTI-IL6 MONOCLONAL ANTIBODY THERAPY IN EXPERIMENTAL AUTOIMMUNE
GLOMERULONEPHRITIS IN THE CD1 MOUSE
Reynolds, J1, Marshall, D3, Shaw, S3, Cook, T2,
Gelinas, R E4, Pusey, C D1
1Renal Section, Division of Medicine, and 2Department of
Histopathology, Imperial College London, 3UCB Celltech, Slough, 4Battelle
Seatle Research Centre, Seatle,USA.
P265: URINARY
MONOCYTE CHEMOATTRACTANT PROTEIN-1 CORRELATES WITH DISEASE ACTIVITY IN
PAEDIATRIC LUPUS NEPHRITIS
Marks, S D*1,2, Shah, V2, Hasson, N3, Pilkington, C3,
Tullus, K1
1Paediatric Nephrology, 3Paediatric Rheumatology, Great
Ormond Street Hospital for Children NHS Trust, 2UCL Institute of
Child Health, London
P266:
NEOLYMPHANGIOGENESIS IN DIABETIC KIDNEY DISEASE
Conway B1, Rennie J1, Linghong H2, Haylor J2,
Johnson T2, Hughes J1,
1University of Edinburgh, 2Sheffield Kidney Institute
P267:
ERYTHROPOEITIN MODULATES APOPTOSIS RELATED GENE EXPRESSION IN HUMAN
MICROVASCULAR ENDOTHELIAL AND RENAL TUBULAR EPITHELIAL CELLS
De Freitas, D1, Coupes, B1, Picton, M1,
Greener, I2, Tellez, J2, Brenchley, P1
1Manchester Royal Infirmary,2University of Manchester
P268: ABOLITION OF
APOPTOSIS IN RENAL ISCHEMIA REPERFUSION INJURY BY DEXAMETHASONE DUE TO NOVEL
NON-GENOMIC RAPID, TRANSIENT PHOSPHORYLATION OF EXTRACELLULAR SIGNAL-RELATED
KINASES (ERK)- 1/2.
Kumar, S, Allen, D, Kieswich, J, Harwood, S, Salvatore, C, Nimesh S. Patel,
A, Raftery, M J, Thiemermann, C, Yaqoob, M J, Queen Mary University of London.
P269:
DISCORDANT PHENOTYPES OF BONE MARROW-DERIVED AND RESIDENT PERITONEAL
MACROPHAGES OF NOD AND C57BL/6 MICE.
Houlberg K, Kipari T, Ferenbach D, Clay S, Hughes J, University of Edinburgh
P270: SMOKERS ON
DIALYSIS HAVE HIGHER PLASMA ATHEROGENIC PRO-INFLAMMATORY CYTOKINES AND PRODUCE
MORE VEGF IN VITRO THAN NON SMOKERS
Vardhan A, Summers A, Wright J, Gokal R, Hutchison A, Brenchley P,
Manchester Royal Infirmary
P271: RECURRENT
PERITONITIS CAUSES A DYSREGULATION OF THE PERITONEAL CYTOKINE NETWORK
Fielding CA1, McLoughlin R M2, Parker C2,
Roberts G2, Colmont C1, Kift-Morgan A2,
Williams J D2, Jones S A1, Topley N1
1 Department of Medical Biochemistry and Immunology and 2
Institute of Nephrology, Cardiff University, Cardiff
P272: DEFINING
THE KINETICS OF TRANSCRIPTION FACTOR AND INTERFERON-GAMMA EXPRESSION IN
EFFECTOR T CELLS
Gökmen M R, Lord G M, Guy’s Hospital and St. Thomas’ and King’s College
London
P273: UK RENAL
RESEARCH PRIORITIES: A COMPARISON OF SURVEYS OF PATIENT OPINIONS AND
INVESTIGATOR ACTIVITIES
Smith A C1, Davies E2, 1Leicester General
Hospital (on behalf of the Renal Association Research Committee), 2Kidney
Research UK, Peterborough
P274: THE
ROLE OF SIGNALLING THROUGH INTRACELLULAR INORGANIC PHOSPHATE (PI) IN SENSING OF
HYPERPHOSPHATAEMIA BY CULTURED HUMAN VASCULAR SMOOTH MUSCLE CELLS (HVSMC)
Kosmadakis, G, Brown, J, Bevington, A, University of Leicester
P275: NITROGEN
CONTAINING BISPHOSPHONATES INHIBIT MINERALISATION OF CALCIFYING BOVINE VASCULAR
SMOOTH MUSCLE CELLS: ROLE OF FARNESYL PYROPHOSPHATE
Sinha, S1 Siddals, K W1, Gibson, J M1,
Canfield , A E2 Kalra, P A1, 1Hope Hospital, 2University
of Manchester
P276: PARADOXICAL
PRO- AND ANTI-APOPTOTIC EFFECTS OF INTERFERON-Y(IFNΓ) ON ERYTHROPOIESIS:
IMPLICATIONS FOR OPTIMIZING ESA THERAPY
Allen D, Harwood S, Raftery M, Yaqoob M, Barts and the London School of
Medicine and Dentistry, Queen Mary, London,
P277: CO-CULTURE
WITH ENDOTHELIAL CELLS DOES NOT ENHANCE PROPLATELET FORMATION IN PRIMARY BONE
MARROW DERIVED RAT MEGAKARYOCYTES
Spencer N B, Savill J, Brown S, University of Edinburgh
P278: THE
ACIDOSIS-SENSING AMINO ACID TRANSPORTER SNAT2 ACTIVATES PROTEOLYSIS IN L6
MUSCLE CELLS BY SIGNALLING THROUGH PI-3-KINASE AND PROTEIN KINASE B
Bevington A1 Evans K1, Brown J1, Herbert T
P2, Departments of 1Infection, Immunity &
Inflammation, & 2Cell Physiology & Pharmacology, University
of Leicester
P279:
INHIBITION OF THE ACIDOSIS-SENSING L-GLN TRANSPORTER SNAT2 IMPAIRS
PROLIFERATION OF LBRM-TG6 MOUSE T-LYMPHOCYTES
Kosmadakis G1, Clapp E2, Viana J2, Brown J1,
Evans K1, Smith A1, Bishop N2 Bevington A1
1Leicester General Hospital, 2Loughborough University
P280: EXPRESSION OF
CLAUDIN PROTEINS ALONG THE HUMAN NEPHRON
Kirk, A1 2, Campbell, S1 2,
Bass, P1, Mason, J2, Collins, J1
1University of Southampton Medical School, 2Queen
Alexandra Hospital, Portsmouth
P281: MODULATION
OF URETERIC SMOOTH MUSCLE CONTRACTILITY BY UROPATHOGENIC E.COLI (UPEC)
Floyd, R1, Bakran, A2, Winstanley, C1, Wray, S1,
Burdyga, T1, 1University of Liverpool, 2Royal
Liverpool University Hospital
P282:
EXTRACELLULAR CALCIUM-SENSING RECEPTOR MEDIATED SIGNALLING AND ITS ROLE IN THE
REGULATION OF PROLIFERATION AND APOPTOSIS IN HUMAN VASCULAR SMOOTH MUSCLE CELLS
Molostvov, G1, Bennett, J2, Bland,R2 ,
Zehnder, D1
1The Clinical Sciences Research Institute, 2The
BioMedical Research Institute, The University of Warwick
P283: THE D
SUBUNIT PLAYS A CENTRAL ROLE IN HUMAN KIDNEY V-ATPASES
Smith, A N, Sorrell, S L, Karet, F E, University of Cambridge
P284: THE KEY
ANABOLIC L-GIN TRANSPORTER SNAT2 IS ACUTELY INHIBITED BY GLUCOCORTICOID STRESS
IN L6 SKELETAL MUSCLE CELLS
Clapp E1, Butler H2, Kosmadakis G2, Brown J2,
Nasim Z2, Bevington A2, 1Loughborough
University, 2University of Leicester
TGFBETA, BMP7 AND
TUBULAR CELLS
P285: THE
TRANSFORMING GROWTH FACTOR BETA-1 3’-UNTRANSLATED REGION CONTRIBUTES TO
POSTRANSCRIPTIONAL REGULATION OF TGF BETA SYNTHESIS
Bennagi R, Krupa A, Martin J, Jenkins R, Phillips A O, Fraser D J, Cardiff
University
P286: EFFECT OF
CICLOSPORIN A AND TGF-Β ON EPITHELIAL BARRIER PROPERTIES OF RENAL TUBULAR
EPITHELIUM
Kirk A1 2, Hardyman M1, Campbell S1
2,Bass P1, Mason J2, Collins J1
1University of Southampton Medical School, 2Queen Alexandra Hospital
P287:
DIFFERENTIAL DOSE DEPENDENT BMP-7 SIGNALLING IN PROXIMAL TUBULE EPITHELIAL
CELLS AND IMPLICATION IN FIBROSIS
Motazed R, Colville-Nash P, Kwan J T C, Dockrell M E C, South West Thames
Institute for Renal Research, Carshalton
P288:
ANTIFIBROTIC EFFECTS OF BMP 7 IN PTECS CULTURE IS ID2 MEDIATED
Veerasamy, M, Colville-Nash, P R, Kwan, J T C, & Dockrell, M E C
Epsom & St.Helier University Hospitals NHS Trust
P289: IDENTIFYING
GENES INVOLVED IN THE PATHOGENESIS OF PROXIMAL TUBULAR PROTEINURIA USING ENU
MUTAGENISED MICE
Wang, W1, Beaujean, V2, Müller. P-S1, Bentley,
L1, Devuyst. O 2 Cox, R D1
1Mammalian Genetics Unit, MRC Harwell, Oxfordshire,2Université
catholique de Louvain Medical School, Brussels, Belgium
P290: HIGH
AMBIENT GLUCOSE CONCENTRATIONS INDUCE A RAPID ACTIVATION AND EXTERNALIZATION OF
CALPAIN IN PROXIMAL TUBULAR EPITHELIAL CELLS (LLC-PK1)
Harwood, S, Allen, D, Raftery, M, Yaqoob,M
Barts and the Royal London School of Medicine and Dentistry, London
P291: EVIDENCE
FOR A ROLE FOR ERK5 IN EGF-INDUCED RENAL EPITHELIAL CELL SURVIVAL – A POSSIBLE
ROLE FOR MEF2C?
Browne J, Paramasivami K, Dockrell M, Colville-Nash P, Baines D1
St Helier Hospital, 1St George’s Hospital Medical School
P292: NEPHRIN
REGULATED NF-kB ACTIVATION MEDIATES GLOMERULAR INJURY IN VIVO
Koziell A1, Hussain S1, Romio L1,
Mathieso, P2, Mosca, J3, Diaz-Meco, M3, Salee, M2,
Scambler P 1
1Institute of Child Health, London, 2 Southmead Hospital,
Bristol, 3University of Cincinnati, USA.
P293: HUMAN
PODOCYTES EXPRESS ENDOTHELIN (ET-1) RECEPTORS AND DISPLAY ETA
RECEPTOR-DEPENDENT ET-1 & INTERLEUKIN-6 PRODUCTION
Dhaun N, Owen E, Kipari T, Saleem M A, Mathieson PW, Goddard J, Webb D J, Kluth
DC, University of Edinburgh
P294:
PODOPLANIN IS THE LIGAND FOR THE NEWLY DISCOVERED PLATELET RECEPTOR CLEC – 2
AND TRIGGERS PLATELET AGGREGATION
O’Callaghan1 C, Christou C1, Pearce A2, Watson
A1, Mistry A1, Fenton-May A1, Pollitt A2,
Watson S2,
1Oxford Kidney Unit and University of Oxford, 2University
of Birmingham
P295:
MACROPHAGE-PODOCYTE INTERACTIONS AND THE ROLE OF THE ENDOTHELIN SYSTEM
Dhaun N, Evans L C, Saleem M A, Mathieson PW, Goddard J, Webb D J, Kluth D
C, University of Edinburgh
P296:
GLYCOGEN SYNTHASE KINASE 3b (GSK3b) REGULATES PODOCYTE DIFFERENTIATION AND
PROCESS FORMATION THROUGH THE MICROTUBULE CYTOSKELETON
Papakrivopoulou, J, Blaber,R, Norman, J, Connolly, J O, Royal Free and
University College London Medical School
FIBROSIS
P297: THE
INHIBITION OF EARLY COMPENSATORY RENAL GROWTH IN SUBTOTAL NEPHRECTOMY MODEL BY
A CYCLIN-DEPENDENT KINASE INHIBITOR
Nutter F1, Haylor J1, el Nahas M1, Frame S2,
Khwaja A1, 1University of Sheffield 2Cyclacel
Ltd, Dundee
298: DISCOVERY OF
HERBAL MEDICINES WITH IN VITRO ANTI-FIBROTIC ACTIVITIES
HU, Q1, HENDRY, B1, XU, Q2
1Kings College London, 2Chinese Academy of Medical
Sciences & Peking Union Medical School
P299: MACROPHAGE
EXPRESSION OF MMPS/TIMPS DURING PROGRESSIVE RENAL FIBROSIS
Vernon MA, Hartland SN, Clay M, Iredale JP and Hughes J, University of
Edinburgh
P300: TGFb
STIMULATED EMT OF RAT TUBULAR EPITHELIAL CELLS INDUCES MICRORNA-21 AND -192
EXPRESSION
Denby L, Work L M, Jardine A, Baker A H, University of Glasgow
P301: ROLE OF
N-METHYL-D-ASPARTATE RECEPTOR (NMDA-R) IN RENAL EPITHELIAL-MESENCHYMAL
TRANSITION IN VITRO
Bozic M1, de Rooij J2, Fernandez E1,
Valdivielso J M1, 1University Hospital Arnau de Vilanova,
Lleida, Spain.
2Netherlands Cancer Institute, Amsterdam, Netherlands
P302: EFFECT
OF HYPOXIA ON COLLAGEN IΑ2 (COLIA2) GENE EXPRESSION IN HUMAN FIBROBLASTS
Irtiza-Ali A1, 2, Fragiadaki M1,
Bou-Gharios G1, H Maxwell P H1
1Hammersmith Hospital, 2North Western Deanery for
Postgraduate Medicine
P303: DIFFERENTIAL
EFFECT OF CNI TREATMENT IN T CELL ACTIVATION ON T LYMPHOCYTES FROM RENAL
TRANSPLANT RECIPIENTS
Perucha E1, Hernandez-Fuentes M P1, Sagoo P1,
Hilton R1, Sergeant R2, Waters J2, Warrens R2,
Lechler I1
1Guy's and St Thomas' Hospital and King's College London, 2Imperial
College London and Hammersmith Hospital
P304: PRE-TRANSPLANT
IMPDH ACTIVITY IN PERIPHERAL BLOOD MONONUCLEAR CELLS IS LOWER IN FEMALES OF
ASIAN AND BLACK ETHNICITY
Shah S, Harwood SH, Allen DA, Raftery MJ and Yaqoob MM, Barts and the London
School of Medicine and Dentistry, London
P305: THE EFFECT
OF IMMUNO-SUPPRESSANT DRUGS ON INNATE IMMUNITY
Hopcraft, L1, Howse, M2, Bakran, A2, Edwards,
S W1
1 University of Liverpool, 2 Royal Liverpool and
Broadgreen University Hospitals
P306: MICROBEAD
METHOD ALLOWS FREQUENT MONITORING OF HLA ANTIBODY LEVELS, AND MAY BE USEFUL AS
CELLULAR CROSSMATCHING METHODS
Higgins, R1, Briggs, D2Lowe, D2, Hathaway, M2,
Hamer, R3, Krishnan, N3, Zehnder, D3
1University Hospital, Coventry, 2NHS Blood and
Transplant, Birmingham, 3University of Warwick
P307:
POST-TRANSPLANT DETECTION OF ANTI-HLA ANTIBODIES: RISK FACTORS AND CLINICAL
RELEVANCE
Hernandez-Fuentes, M P1, Perucha, E1, Sagoo, P1,
Ballows, A A2, Hilton, R1, Sergeant, R2,
Waters, J2, Roberts, I3, Wood, K J3, Warrens, J A2,
Lechler, R I1
1Guy's and St Thomas' Hospital and King's College London, 2Imperial
College London and Hammersmith Hospital, 3University of Oxford and John
Radcliffe Hospital
P308: CAN A
QUANTATIVE ESTIMATE OF ASSOCIATION BETWEEN ACUTE REJECTION AND CHRONIC
NEPHROPATHY BE SUMMARIZED FROM THE PUBLISHED LITERATURE
Briggs, A1, Wu, Olivia1, Lewis, G2, Levy, A3,
Jardine, A1
1University of Glasgow, 2Roche Products, 3University
of British Columbia
P309: FcgRIIIb:
COPY NUMBER VARIATION, IMMUNE COMPLEX CLEARANCE AND AUTOIMMUNITY
Willcocks, L C1,2, Lyons, P A1,2,
Clatworthy, M R1,2, Robinson, J I3, Yang, W4, Newland, S
A1,2, Plagnol, V,1,5, McGovern, N2,
Condliffe, A2, Chilvers, E R2, Adu, D6, Jolly, E1,2,
Watts, R7, Lau, Y L4, Morgan, A W3, Nash, G8, Smith, K G C1,2.
1Cambridge Institute for Medical Research, 2University of
Cambridge, 3 St. James's University Hospital, Leeds, 4Queen Mary Hospital,
University of Hong Kong, 5University of Cambridge, 6University of Birmingham,
7University of East Anglia, 8University of Birmingham.
P310:
O-GALACTOSYLATION PATTERNS OF SERUM IGA1 IN PATIENTS WITH IGA NEPHROPATHY
REMAIN CONSTANT OVER LONG PERIODS OF TIME
Smith A C, Mendichovsky I, Dickinson S J, Molyneux K, Feehally J, Barratt J,
Leicester General Hospital
P311:THE EFFECT
OF ACIDOSIS ON INNATE IMMUNITY
Hopcraft L1, Howse M2, Bakran A2, Edwards
S W1
1 University of Liverpool, 2 Royal Liverpool and
Broadgreen University Hospitals
P312: B CELL
CYTOKINES IN PATIENTS WITH SLE AND VASCULITIS POST-RITUXIMAB TREATMENT: A PILOT
STUDY
Shah A J, Jones R D, Jayne D, Smith K G, Clatworthy M R, Addenbrooke’s
Hospital, Cambridge
P313: AN
ASSOCIATION BETWEEN CYTOMEGALOVIRUS INFECTION, CD28- T-CELLS AND DISEASE
SEVERITY IN ANTI-NEUTROPHIL CYTOPLASM ANTIBODY ASSOCIATED VASCULITIS
Morgan MD, Drayson MT, Moss P, Harper L, University of Birmingham
P314:
IDENTIFICATION AND MANIPULATION OF NOVEL REGULATORS OF TH17 DEVELOPMENT IN
HUMANS
Suddason, T, Jackson, I, Wright, H, Taams, S, Lombardi, G, Lord, G
Guy's and St Thomas' Hospital and King's College London
P315: A
LONGITUDINAL STUDY OF CIRCULATING B AND T CELL SUBSETS IN 20 PATIENTS WITH
ANCA-ASSOCIATED VASCULITIS TREATED WITH RITUXIMAB
Ferraro A J, Drayson M T,MacLennan I C M, Savage C O S, Birmingham
University
|